{"protocolSection":{"identificationModule":{"nctId":"NCT01177397","orgStudyIdInfo":{"id":"CC-223-ST-001"},"organization":{"fullName":"Celgene","class":"INDUSTRY"},"briefTitle":"Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma","officialTitle":"A Phase 1/2, Multi-Center, Open-Label, Dose Finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the mTOR Kinase Inhibitor CC-223 Administered Orally to Subjects With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Multiple Myeloma"},"statusModule":{"statusVerifiedDate":"2022-12","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2010-07-20","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2016-11-15","type":"ACTUAL"},"completionDateStruct":{"date":"2016-12-09","type":"ACTUAL"},"studyFirstSubmitDate":"2010-08-05","studyFirstSubmitQcDate":"2010-08-06","studyFirstPostDateStruct":{"date":"2010-08-09","type":"ESTIMATED"},"resultsFirstSubmitDate":"2022-08-30","resultsFirstSubmitQcDate":"2022-10-21","resultsFirstPostDateStruct":{"date":"2022-11-15","type":"ACTUAL"},"dispFirstSubmitDate":"2017-11-13","dispFirstSubmitQcDate":"2017-11-13","dispFirstPostDateStruct":{"date":"2017-11-14","type":"ACTUAL"},"lastUpdateSubmitDate":"2022-12-09","lastUpdatePostDateStruct":{"date":"2022-12-13","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Celgene","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"The main purpose of this first human study with CC-223 is to assess the safety and action of a new class of experimental drug (dual mTOR inhibitors) in patients with advanced tumors unresponsive to standard therapies and to determine the appropriate dose and tumor type for later-stage clinical trials.","detailedDescription":"Initially, patients will be treated with oral CC-223 for one month. During this time, various tests (involving blood and urine collections, ECGs, etc) will be performed. Those whose tumors stabilize or regress may continue receiving treatment for as long as they benefit from CC-223. Different dose levels of CC-223 will be tested in a dose-rising study design."},"conditionsModule":{"conditions":["Multiple Myeloma","Diffuse Large B-Cell Lymphoma","Glioblastoma Multiforme","Hepatocellular Carcinoma","Non-Small Cell Lung Cancer","Neuroendocrine Tumors of Non-Pancreatic Origin","Hormone Receptor-Positive Breast Cancer"],"keywords":["Advanced solid malignant neoplasms,Non-Hodgkin Lymphoma,","Multiple Myeloma"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE1","PHASE2"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":226,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"CC-223","type":"EXPERIMENTAL","description":"All patients will receive CC-223, but serial patient groups will receive different dose levels in Phase 1. The number of groups will be determined by the number of dose levels required to establish dose-limiting toxicity.","interventionNames":["Drug: CC-223"]}],"interventions":[{"type":"DRUG","name":"CC-223","description":"Part A: (closed to enrollment) Dose level starts with 7.5mg daily taken by mouth in cycles of 28 days. Level increases for different patient cohorts in 100% or 50% increments until optimal dose level is established for further study. Treatment continues for as long as patient benefits (i.e., until disease progression or unacceptable toxicity). Part B: (closed to enrollment) Optimal dose is administered in 28 day cycles until disease progression.","armGroupLabels":["CC-223"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Part A: Number of Participants With Dose-limiting Toxicities","description":"A dose-limiting toxicity was defined as: - ≥ Grade 3 (per Common Terminology Criteria for Adverse Events \\[CTCAE\\] Version 4) clinically relevant adverse event (AE) or laboratory abnormality suspected to be related to CC-223 that commenced within 30 days of first dose, except alopecia, Grade 3 rash of the acneiform or maculopapular type for \\< 5 days, Grade 3 diarrhea or vomiting lasting \\< 72 hours, repeated occurrence of Grade 3 hyperuricaemia in subjects with Grade 3 hyperuricemia at baseline, hyperglycemia, hematologic and liver function test (LFT) abnormalities due to disease progression. - Grade 2 fasting hyperglycemia lasting \\> 14 days or ≥ Grade 3 lasting \\> 4 days despite optimal medical treatment. - Hematological toxicities including febrile neutropenia, Grade 4 neutropenia or thrombocytopenia for \\> 7 days, or Grade 3/4 thrombocytopenia with clinically significant bleeding. - Grade 4 LTFs - AE suspected to be CC-223 related necessitating dose reduction during cycle 1.","timeFrame":"From first dose up to 30 days after first dose"},{"measure":"Maximum Observed Plasma Concentration (Cmax) of CC-223","description":"Cmax is defined as the maximum observed concentration (in plasma), obtained directly from the observed concentration versus time data. Plasma CC-223 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL.","timeFrame":"Cycle 1 Day 1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose and Day 15: pre-dose, 0.5, 1, 1.5, 3, 5, and 8 hours post-dose"},{"measure":"Time to Maximum Concentration (Tmax) of CC-223","description":"Tmax is defined as the time to Cmax, obtained directly from the observed concentration versus time data. Plasma CC-223 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL.","timeFrame":"Cycle 1 Day 1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose and Day 15: pre-dose, 0.5, 1, 1.5, 3, 5, and 8 hours post-dose"},{"measure":"Area Under the Plasma Concentration-Time Curve From Time 0 to the Last Measurable Concentration (AUCt) for CC-223","description":"Plasma CC-223 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL.","timeFrame":"Cycle 1 Day -1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose and Day 15: pre-dose, 0.5, 1, 1.5, 3, 5, and 8 hours post-dose"},{"measure":"Area Under the Concentration Time-Curve From 0-24 Hours After a Dose (AUC0-24) for CC-223","description":"AUC0-24 is defined as the area under the concentration-time curve from Time 0 to 24 hours after a dose. Plasma CC-223 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL.","timeFrame":"0 to 24 hours post-dose on Day -1 and Day 15"},{"measure":"Area Under the Plasma Concentration-Time Curve From Time 0 Extrapolated to Infinity (AUCinf) For CC-223","description":"AUCinf is defined as the area under the concentration-time curve from Time 0 extrapolated to infinity. Plasma CC-223 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. AUCinf was not assessed following multiple dosing as the blood sampling schedule on Day 15 did not allow robust assessment of the terminal elimination rate constant.","timeFrame":"Cycle 1 Day 1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose and Day 15: pre-dose, 0.5, 1, 1.5, 3, 5, and 8 hours post-dose"},{"measure":"Part A: Terminal Elimination Phase Half-Life (T1/2) of CC-223","description":"Plasma CC-223 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. T1/2 was not assessed following multiple dosing as the blood sampling schedule on Day 15 did not allow robust assessment of the terminal elimination rate constant.","timeFrame":"Cycle 1 Day -1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose"},{"measure":"Apparent Total Body Clearance (CL/F) of CC-223","description":"CL/F is defined as the apparent total body clearance when dosed orally, calculated as Dose/AUCinf. Plasma CC-223 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL.","timeFrame":"Cycle 1 Day 1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose and Day 15: pre-dose, 0.5, 1, 1.5, 3, 5, and 8 hours post-dose"},{"measure":"Apparent Volume of Distribution (Vz/F) of CC-223","description":"Plasma CC-223 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. VZ/F was not assessed following multiple dosing as the blood sampling schedule on Day 15 did not allow robust assessment of the terminal elimination rate constant.","timeFrame":"Cycle 1 Day -1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose"},{"measure":"Part B: Progression Free Survival (PFS) Rate at 6 Months for GBM Participants","description":"Progression free survival rate of GBM participants at 6 months is defined as the percentage of participants without progressive disease per Evaluation Criteria in Solid Tumors (RECIST) 1.1 6 months after starting study treatment. Progressive disease is defined as the appearance of one or more new lesions and/or unequivocal progression of existing non-target lesions.","timeFrame":"From first dose to 6 months"}],"secondaryOutcomes":[{"measure":"Part A: Percent Change From Baseline in Levels of Phosphorylated Ribosomal Protein S6 (pS6RP) in Stimulated B Cells","description":"Phosphorylated S6RP is a biomarker for inhibition of the mammalian target of rapamycin complex 1 (mTORC1). Phosphorylated S6RP was measured in stimulated B cells via flow cytometry. The raw measurements were expressed as median fluorescence intensity (MFI). MFI values were normalized against calibration beads using a linear regression transformation carried out on a log-log scale and reported as equivalent reference fluorophores (ERF). The biomarker evaluable population included all subjects who took at least one dose of study drug and had at least one non-missing pharmacodynamic (PD) assessment. Results were not available for the single subject treated in the 7.5-mg dose group and for one of the two subjects treated in the 15-mg dose group.","timeFrame":"Cycle 1 Day -1: 3 hours post-dose and Day 15: 1.5 hours post-dose"},{"measure":"Part A: Percent Change From Baseline in Levels of Phosphorylated Elongation I Initiation Binding Protein (p4E-BP1) in Stimulated T Cells","description":"Phosphorylated 4E-BP1 is a biomarker for inhibition of the mammalian target of rapamycin complex 1 (mTORC1). Phosphorylated 4E-BP1 was measured in stimulated T cells via flow cytometry. The raw measurements were expressed as median fluorescence intensity (MFI). MFI values were normalized against calibration beads using a linear regression transformation carried out on a log-log scale and reported as equivalent reference fluorophores (ERF). The biomarker evaluable population included all subjects who took at least one dose of study drug and had at least one non-missing pharmacodynamic (PD) assessment. Results were not available for the single subject treated in the 7.5-mg dose group and for one of the two subjects treated in the 15-mg dose group.","timeFrame":"Cycle 1 Day -1: 3 hours post-dose and Day 15: 1.5 hours post-dose"},{"measure":"Part A: Percent Change From Baseline in Levels of Phosphorylated Protein Kinase B (pAKT) in Stimulated Monocytes","description":"Phosphorylated AKT is a biomarker for inhibition of the mammalian target of rapamycin complex 2 (mTORC2). Phosphorylated AKT was measured in stimulated monocytes via flow cytometry. The raw measurements were expressed as median fluorescence intensity (MFI). MFI values were normalized against calibration beads using a linear regression transformation carried out on a log-log scale and reported as equivalent reference fluorophores (ERF). The biomarker evaluable population included all subjects who took at least one dose of study drug and had at least one non-missing pharmacodynamic (PD) assessment. Results were not available for the single subject treated in the 7.5-mg dose group and for one of the two subjects treated in the 15-mg dose group.","timeFrame":"Cycle 1 Day -1: 3 hours post-dose and Day 15: 1.5 hours post-dose"},{"measure":"Part B: Percent Change From Baseline in p4E-BP1 in Monocytes by Tumor Cohort","description":"Phosphorylated 4E-BP1 is a biomarker for inhibition of the mammalian target of rapamycin complex 1 (mTORC1). Phosphorylated 4E-BP1 was measured in stimulated monocytes via flow cytometry. MFI values were determined and converted to molecules of equivalent fluorescence label (MEFL) by normalizing against calibration beads. The biomarker evaluable population included all subjects who took at least one dose of study drug and had at least one non-missing pharmacodynamic (PD) assessment. Data is reported by T-cell subsets known as clusters of differentiation (CD).","timeFrame":"Cycle 1 Day 1: 1.5 hours post-dose and Day 15: 1.5 hours post-dose"},{"measure":"Part B: Percent Change From Baseline in p4E-BP1 in Monocytes in the HCC and NET Cohorts by Dose","description":"Phosphorylated 4E-BP1 is a biomarker for inhibition of the mammalian target of rapamycin complex 1 (mTORC1). Phosphorylated 4E-BP1 was measured in stimulated monocytes via flow cytometry. MFI values were determined and converted to molecules of equivalent fluorescence label (MEFL) by normalizing against calibration beads. The biomarker evaluable population included all subjects who took at least one dose of study drug and had at least one non-missing pharmacodynamic (PD) assessment. Data is reported by T-cell subsets known as clusters of differentiation (CD).","timeFrame":"Cycle 1 Day 1: 1.5 hours post-dose and Day 15: 1.5 hours post-dose"},{"measure":"Part B: Percent Change From Baseline in Levels of pAKT in Monocytes by Tumor Cohort","description":"Phosphorylated AKT is a biomarker for inhibition of the mammalian target of rapamycin complex 2 (mTORC2). Phosphorylated AKT was measured in stimulated monocytes via flow cytometry. MFI values were determined and converted to molecules of equivalent fluorescence label (MEFL) by normalizing against calibration beads. The biomarker evaluable population included all subjects who took at least one dose of study drug and had at least one non-missing pharmacodynamic (PD) assessment.","timeFrame":"Cycle 1 Day 1: 1.5 hours post-dose and Day 15: 1.5 hours post-dose"},{"measure":"Part B: Percent Change From Baseline in Levels of pAKT in Monocytes in the HCC and NET Cohorts by Dose","description":"Phosphorylated AKT is a biomarker for inhibition of the mammalian target of rapamycin complex 2 (mTORC2). Phosphorylated AKT was measured in stimulated monocytes via flow cytometry. MFI values were determined and converted to molecules of equivalent fluorescence label (MEFL) by normalizing against calibration beads. The biomarker evaluable population included all subjects who took at least one dose of study drug and had at least one non-missing pharmacodynamic (PD) assessment.","timeFrame":"Cycle 1 Day 1: 1.5 hours post-dose and Day 15: 1.5 hours post-dose"},{"measure":"Part B: Percent Change From Baseline in pS6RP Levels in Tumor Tissue by Tumor Type","description":"Tumor tissue biopsies were performed at Baseline and on Day 15 3 hours post dose. Levels of pS6RP were quantified using immunohistochemical (IHC) methods.","timeFrame":"Up to Cycle 1 Day 15 3 hours post dose"},{"measure":"Part A: Overall Response Rate","description":"Tumor response was based on Investigator assessment according to Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 for solid tumors (NSCLC, HCC, NET, and HRPBC), and the International Working Group Criteria (IWC) for DLBCL. Overall Response Rate is defined as the percentage of participants with a best overall response of complete response or partial response. Complete response is defined as the disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to \\<10 mm. Partial response is defined as at least a 30% decrease in the sum of diameters of target lesions, taking as reference the baseline sum diameters. In Part A, participants with MM and participants with GBM were not evaluated for tumor response.","timeFrame":"From first dose up to tumor response (approximately 11 months)"},{"measure":"Part B: Overall Response Rate","description":"Tumor response was based on Investigator assessment according to Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 for solid tumors (NSCLC, HCC, NET, and HRPBC), International Working Group Criteria (IWC) for DLBCL, and the International Myeloma Working Group (IMWG) criteria for MM. For GBM, Responses Assessment for Neuro-Oncology Working Group (RANO) criteria were used for tumor response, using the post resection MRI scan as the baseline. Overall Response Rate is defined as the percentage of participants with a best overall response of complete response or partial response. Complete response is defined as the disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to \\<10 mm. Partial response is defined as at least a 30% decrease in the sum of diameters of target lesions, taking as reference the baseline sum diameters.","timeFrame":"From first dose up to tumor response (approximately 36 months)"},{"measure":"Maximum Observed Concentration (Cmax) of Metabolite M1","description":"Cmax is defined as the maximum observed concentration (in plasma), obtained directly from the observed concentration versus time data. Plasma metabolite M1 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 10.0 ng/mL.","timeFrame":"Cycle 1 Day -1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose and Day 15: pre-dose, 0.5, 1, 1.5, 3, 5, and 8 hours post-dose"},{"measure":"Time to Maximum Concentration (Tmax) of Metabolite M1","description":"Tmax is defined as the time to Cmax, obtained directly from the observed concentration versus time data. Plasma metabolite M1 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 10.0 ng/mL.","timeFrame":"Cycle 1 Day -1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose and Day 15: pre-dose, 0.5, 1, 1.5, 3, 5, and 8 hours post-dose"},{"measure":"Area Under the Plasma Concentration-Time Curve From Time 0 to the Last Measurable Concentration (AUCt) for Metabolite M1","description":"AUCt is defined as the area under the concentration-time curve from Time 0 to the time of the last quantifiable concentration. Plasma metabolite M1 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 10.0 ng/mL.","timeFrame":"Cycle 1 Day -1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose and Day 15: pre-dose, 0.5, 1, 1.5, 3, 5, and 8 hours post-dose"},{"measure":"Area Under the Concentration Time-Curve From 0-24 Hours After a Dose (AUC0-24) for Metabolite M1","description":"AUC0-24 is defined as the area under the concentration-time curve from Time 0 to 24 hours after a dose. Plasma metabolite M1 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 10.0 ng/mL.","timeFrame":"0 to 24 hours post-dose on Day -1 and Day 15"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Histologically-confirmed advanced solid tumor, Non-Hodgkin Lymphoma or multiple myeloma\n* Patients have not tolerated or progressed on standard therapy, and no further standard therapy is available\n* Archival and screening tumor biopsy\n* Eastern Cooperative Oncology Group (ECOG) performance status 0-1 (solid tumors), 0-2 (hematologic malignancy)\n* Adequate organ function\n\nExclusion Criteria:\n\n* Prior systemic cancer-directed treatments or investigational drugs within 4 weeks or 5 half lives, whichever is shorter, prior to starting study drug or who have not recovered from side effects of such therapy. Subjects must have recovered from any effects of recent radiotherapy that might confound the safety evaluation of study drug\n* Symptomatic brain metastases (prior Rx and stable metastases are OK)\n* Acute or chronic liver or renal disease or pancreatitis\n* Diarrhea ≥ Grade 2, impaired GI absorption\n* Impaired cardiac function\n* Diabetes requiring Rx, glucose \\>126 mg/dL, HbA1c ≥6.5%\n* Peripheral neuropathy ≥ Grade 2\n* Pulmonary fibrosis\n* Known HIV infection\n* Known chronic hepatitis B or C virus (HBV/HCV) infection, unless comorbidity in subjects with HCC\n* Pregnant, inadequate contraception\n* Most concurrent second malignancies","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Bristol-Myers Squibb","affiliation":"Bristol-Myers Squibb","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Cedars-Sinai Medical Center","city":"Los Angeles","state":"California","zip":"90048","country":"United States","geoPoint":{"lat":34.05223,"lon":-118.24368}},{"facility":"UCLA Neuro-Oncology Program","city":"Los Angeles","state":"California","zip":"90095","country":"United States","geoPoint":{"lat":34.05223,"lon":-118.24368}},{"facility":"University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center","city":"San Francisco","state":"California","zip":"94115","country":"United States","geoPoint":{"lat":37.77493,"lon":-122.41942}},{"facility":"Moffitt Cancer Center","city":"Tampa","state":"Florida","zip":"33612","country":"United States","geoPoint":{"lat":27.94752,"lon":-82.45843}},{"facility":"Mayo Clinic Cancer Clinical Studies Unit","city":"Rochester","state":"Minnesota","zip":"55905","country":"United States","geoPoint":{"lat":44.02163,"lon":-92.4699}},{"facility":"Billings Clinic","city":"Billings","state":"Montana","zip":"59102","country":"United States","geoPoint":{"lat":45.78329,"lon":-108.50069}},{"facility":"Hackensack University Medical Center","city":"Hackensack","state":"New Jersey","zip":"07601","country":"United States","geoPoint":{"lat":40.88593,"lon":-74.04347}},{"facility":"NYU Cancer Institute - Bellevue Hospital","city":"New York","state":"New York","zip":"10016","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Sarah Cannon Research Institute Drug Development Unit","city":"Nashville","state":"Tennessee","zip":"37203","country":"United States","geoPoint":{"lat":36.16589,"lon":-86.78444}},{"facility":"Mary Crowley Medical Research Center","city":"Dallas","state":"Texas","zip":"75201","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"Institut Claudius Regaud","city":"Toulouse","zip":"31052","country":"France","geoPoint":{"lat":43.60426,"lon":1.44367}},{"facility":"Institut Gustave Roussy Faculte de Medecine Paris Sud Service de pneumologie","city":"Villejuif","zip":"94800","country":"France","geoPoint":{"lat":48.7939,"lon":2.35992}},{"facility":"Hospital Universitario de Salamanca","city":"Salamanca","zip":"37007","country":"Spain","geoPoint":{"lat":40.96882,"lon":-5.66388}},{"facility":"Hospital Universitario Virgen Del Rocio","city":"Seville","zip":"41013","country":"Spain","geoPoint":{"lat":37.38283,"lon":-5.97317}},{"facility":"Sarah Cannon Research Institute UK","city":"London","zip":"W1G 6AD","country":"United Kingdom","geoPoint":{"lat":51.50853,"lon":-0.12574}},{"facility":"UCL Cancer Institute","city":"London","zip":"WC1E 6BT","country":"United Kingdom","geoPoint":{"lat":51.50853,"lon":-0.12574}}]}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"FG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"FG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"FG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"FG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"FG005","title":"Part B: Non-small Cell Lung Cancer (NSCLC)","description":"Participants with NSCLC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"FG006","title":"Part B: Glioblastoma Multiforme (GBM)","description":"Participants with GBM received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"FG007","title":"Part B: Hepatocellular Carcinoma (HCC)","description":"Participants with HCC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"FG008","title":"Part B: Neuroendocrine Tumor (NET)","description":"Participants with NET received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"FG009","title":"Part B: Diffuse Large B-cell Lymphoma (DLBCL)","description":"Participants with DLBCL received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"FG010","title":"Part B: Multiple Myeloma (MM)","description":"Participants with MM received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"FG011","title":"Part B: Hormone Receptor Positive Breast Cancer (HRPBC)","description":"Participants with HRPBC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"9"},{"groupId":"FG003","numSubjects":"9"},{"groupId":"FG004","numSubjects":"7"},{"groupId":"FG005","numSubjects":"26"},{"groupId":"FG006","numSubjects":"13"},{"groupId":"FG007","numSubjects":"53"},{"groupId":"FG008","numSubjects":"47"},{"groupId":"FG009","numSubjects":"28"},{"groupId":"FG010","numSubjects":"14"},{"groupId":"FG011","numSubjects":"17"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"0"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"9"},{"groupId":"FG003","numSubjects":"9"},{"groupId":"FG004","numSubjects":"7"},{"groupId":"FG005","numSubjects":"26"},{"groupId":"FG006","numSubjects":"13"},{"groupId":"FG007","numSubjects":"53"},{"groupId":"FG008","numSubjects":"47"},{"groupId":"FG009","numSubjects":"28"},{"groupId":"FG010","numSubjects":"14"},{"groupId":"FG011","numSubjects":"17"}]}],"dropWithdraws":[{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"1"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"0"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"1"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"2"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"0"}]},{"type":"Death","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"5"},{"groupId":"FG008","numSubjects":"2"},{"groupId":"FG009","numSubjects":"1"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"0"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"1"},{"groupId":"FG005","numSubjects":"2"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"5"},{"groupId":"FG008","numSubjects":"9"},{"groupId":"FG009","numSubjects":"1"},{"groupId":"FG010","numSubjects":"1"},{"groupId":"FG011","numSubjects":"0"}]},{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"2"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"12"},{"groupId":"FG006","numSubjects":"1"},{"groupId":"FG007","numSubjects":"14"},{"groupId":"FG008","numSubjects":"8"},{"groupId":"FG009","numSubjects":"6"},{"groupId":"FG010","numSubjects":"3"},{"groupId":"FG011","numSubjects":"7"}]},{"type":"Disease progression","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"5"},{"groupId":"FG003","numSubjects":"5"},{"groupId":"FG004","numSubjects":"4"},{"groupId":"FG005","numSubjects":"10"},{"groupId":"FG006","numSubjects":"10"},{"groupId":"FG007","numSubjects":"21"},{"groupId":"FG008","numSubjects":"18"},{"groupId":"FG009","numSubjects":"12"},{"groupId":"FG010","numSubjects":"10"},{"groupId":"FG011","numSubjects":"8"}]},{"type":"Other reasons","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"1"},{"groupId":"FG005","numSubjects":"1"},{"groupId":"FG006","numSubjects":"2"},{"groupId":"FG007","numSubjects":"6"},{"groupId":"FG008","numSubjects":"10"},{"groupId":"FG009","numSubjects":"8"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"2"}]}]}]},"baselineCharacteristicsModule":{"populationDescription":"All treated participants","groups":[{"id":"BG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"BG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"BG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"BG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"BG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"BG005","title":"Part B: Non-small Cell Lung Cancer (NSCLC)","description":"Participants with NSCLC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"BG006","title":"Part B: Glioblastoma Multiforme (GBM)","description":"Participants with GBM received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"BG007","title":"Part B: Hepatocellular Carcinoma (HCC)","description":"Participants with HCC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"BG008","title":"Part B: Neuroendocrine Tumor (NET)","description":"Participants with NET received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"BG009","title":"Part B: Diffuse Large B-cell Lymphoma (DLBCL)","description":"Participants with DLBCL received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"BG010","title":"Part B: Multiple Myeloma (MM)","description":"Participants with MM received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"BG011","title":"Part B: Hormone Receptor Positive Breast Cancer (HRPBC)","description":"Participants with HRPBC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"BG012","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"9"},{"groupId":"BG004","value":"7"},{"groupId":"BG005","value":"26"},{"groupId":"BG006","value":"13"},{"groupId":"BG007","value":"53"},{"groupId":"BG008","value":"47"},{"groupId":"BG009","value":"28"},{"groupId":"BG010","value":"14"},{"groupId":"BG011","value":"17"},{"groupId":"BG012","value":"226"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"55.0","spread":"NA","comment":"Standard Deviation not calculable because data were only collected for 1 participant"},{"groupId":"BG001","value":"54.5","spread":"10.61"},{"groupId":"BG002","value":"53.8","spread":"11.57"},{"groupId":"BG003","value":"46.0","spread":"12.86"},{"groupId":"BG004","value":"49.9","spread":"11.65"},{"groupId":"BG005","value":"62.8","spread":"10.72"},{"groupId":"BG006","value":"55.6","spread":"9.46"},{"groupId":"BG007","value":"60.0","spread":"11.41"},{"groupId":"BG008","value":"62.6","spread":"9.87"},{"groupId":"BG009","value":"53.9","spread":"14.51"},{"groupId":"BG010","value":"60.4","spread":"10.00"},{"groupId":"BG011","value":"53.9","spread":"7.79"},{"groupId":"BG012","value":"58.2","spread":"11.77"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"5"},{"groupId":"BG004","value":"6"},{"groupId":"BG005","value":"12"},{"groupId":"BG006","value":"5"},{"groupId":"BG007","value":"10"},{"groupId":"BG008","value":"28"},{"groupId":"BG009","value":"11"},{"groupId":"BG010","value":"6"},{"groupId":"BG011","value":"17"},{"groupId":"BG012","value":"108"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"14"},{"groupId":"BG006","value":"8"},{"groupId":"BG007","value":"43"},{"groupId":"BG008","value":"19"},{"groupId":"BG009","value":"17"},{"groupId":"BG010","value":"8"},{"groupId":"BG011","value":"0"},{"groupId":"BG012","value":"118"}]}]}]},{"title":"Ethnicity (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Hispanic or Latino","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"2"},{"groupId":"BG006","value":"1"},{"groupId":"BG007","value":"4"},{"groupId":"BG008","value":"2"},{"groupId":"BG009","value":"4"},{"groupId":"BG010","value":"2"},{"groupId":"BG011","value":"1"},{"groupId":"BG012","value":"16"}]},{"title":"Not Hispanic or Latino","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"9"},{"groupId":"BG004","value":"7"},{"groupId":"BG005","value":"20"},{"groupId":"BG006","value":"12"},{"groupId":"BG007","value":"44"},{"groupId":"BG008","value":"45"},{"groupId":"BG009","value":"22"},{"groupId":"BG010","value":"6"},{"groupId":"BG011","value":"11"},{"groupId":"BG012","value":"188"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"4"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"5"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"2"},{"groupId":"BG010","value":"6"},{"groupId":"BG011","value":"5"},{"groupId":"BG012","value":"22"}]}]}]},{"title":"Race","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Asian","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"2"},{"groupId":"BG006","value":"1"},{"groupId":"BG007","value":"10"},{"groupId":"BG008","value":"2"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"1"},{"groupId":"BG012","value":"20"}]},{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"5"},{"groupId":"BG008","value":"1"},{"groupId":"BG009","value":"2"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"0"},{"groupId":"BG012","value":"9"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"7"},{"groupId":"BG003","value":"7"},{"groupId":"BG004","value":"6"},{"groupId":"BG005","value":"20"},{"groupId":"BG006","value":"12"},{"groupId":"BG007","value":"31"},{"groupId":"BG008","value":"43"},{"groupId":"BG009","value":"24"},{"groupId":"BG010","value":"8"},{"groupId":"BG011","value":"10"},{"groupId":"BG012","value":"171"}]},{"title":"Other","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"2"},{"groupId":"BG008","value":"1"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"1"},{"groupId":"BG012","value":"4"}]},{"title":"Missing","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"4"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"5"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"2"},{"groupId":"BG010","value":"6"},{"groupId":"BG011","value":"5"},{"groupId":"BG012","value":"22"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Part A: Number of Participants With Dose-limiting Toxicities","description":"A dose-limiting toxicity was defined as: - ≥ Grade 3 (per Common Terminology Criteria for Adverse Events \\[CTCAE\\] Version 4) clinically relevant adverse event (AE) or laboratory abnormality suspected to be related to CC-223 that commenced within 30 days of first dose, except alopecia, Grade 3 rash of the acneiform or maculopapular type for \\< 5 days, Grade 3 diarrhea or vomiting lasting \\< 72 hours, repeated occurrence of Grade 3 hyperuricaemia in subjects with Grade 3 hyperuricemia at baseline, hyperglycemia, hematologic and liver function test (LFT) abnormalities due to disease progression. - Grade 2 fasting hyperglycemia lasting \\> 14 days or ≥ Grade 3 lasting \\> 4 days despite optimal medical treatment. - Hematological toxicities including febrile neutropenia, Grade 4 neutropenia or thrombocytopenia for \\> 7 days, or Grade 3/4 thrombocytopenia with clinically significant bleeding. - Grade 4 LTFs - AE suspected to be CC-223 related necessitating dose reduction during cycle 1.","populationDescription":"All treated participants in Part A.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From first dose up to 30 days after first dose","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"}]}]}]},{"type":"PRIMARY","title":"Maximum Observed Plasma Concentration (Cmax) of CC-223","description":"Cmax is defined as the maximum observed concentration (in plasma), obtained directly from the observed concentration versus time data. Plasma CC-223 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL.","populationDescription":"All treated participants with available pharmacokinetic data in Part A.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"Geometric Coefficient of Variation","unitOfMeasure":"ng/mL","timeFrame":"Cycle 1 Day 1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose and Day 15: pre-dose, 0.5, 1, 1.5, 3, 5, and 8 hours post-dose","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"classes":[{"title":"Day -1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"45.8","spread":"NA","comment":"Coefficient of Variation not calculable because data were only collected for 1 participant."},{"groupId":"OG001","value":"97.4","spread":"57.5"},{"groupId":"OG002","value":"188","spread":"41.8"},{"groupId":"OG003","value":"269","spread":"65.7"},{"groupId":"OG004","value":"319","spread":"70.0"}]}]},{"title":"Day 15","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"4"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"50.8","spread":"NA","comment":"Coefficient of Variation not calculable because data were only collected for 1 participant."},{"groupId":"OG001","value":"92.0","spread":"162.6"},{"groupId":"OG002","value":"293","spread":"38.8"},{"groupId":"OG003","value":"417","spread":"61.6"},{"groupId":"OG004","value":"480","spread":"88.9"}]}]}]},{"type":"PRIMARY","title":"Time to Maximum Concentration (Tmax) of CC-223","description":"Tmax is defined as the time to Cmax, obtained directly from the observed concentration versus time data. Plasma CC-223 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL.","populationDescription":"All treated participants with available pharmacokinetic data in Part A.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Full Range","unitOfMeasure":"Hours","timeFrame":"Cycle 1 Day 1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose and Day 15: pre-dose, 0.5, 1, 1.5, 3, 5, and 8 hours post-dose","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"classes":[{"title":"Day -1/1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1.00","lowerLimit":"1.00","upperLimit":"1.00"},{"groupId":"OG001","value":"1.25","lowerLimit":"1.00","upperLimit":"1.50"},{"groupId":"OG002","value":"1.55","lowerLimit":"1.00","upperLimit":"3.20"},{"groupId":"OG003","value":"3.00","lowerLimit":"0.967","upperLimit":"3.00"},{"groupId":"OG004","value":"1.50","lowerLimit":"1.00","upperLimit":"5.00"}]}]},{"title":"Day 15","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"4"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1.50","lowerLimit":"1.50","upperLimit":"1.50"},{"groupId":"OG001","value":"2.00","lowerLimit":"1.00","upperLimit":"3.00"},{"groupId":"OG002","value":"1.28","lowerLimit":"0.500","upperLimit":"3.03"},{"groupId":"OG003","value":"1.63","lowerLimit":"0.500","upperLimit":"8.00"},{"groupId":"OG004","value":"1.58","lowerLimit":"1.00","upperLimit":"3.00"}]}]}]},{"type":"PRIMARY","title":"Area Under the Plasma Concentration-Time Curve From Time 0 to the Last Measurable Concentration (AUCt) for CC-223","description":"Plasma CC-223 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL.","populationDescription":"All treated participants with available pharmacokinetic data in Part A.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"Geometric Coefficient of Variation","unitOfMeasure":"ng*h/mL","timeFrame":"Cycle 1 Day -1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose and Day 15: pre-dose, 0.5, 1, 1.5, 3, 5, and 8 hours post-dose","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"classes":[{"title":"Day -1/Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"318","spread":"NA","comment":"Insufficient data values to calculate coefficient of variation."},{"groupId":"OG001","value":"347","spread":"60.2"},{"groupId":"OG002","value":"1204","spread":"37.8"},{"groupId":"OG003","value":"1493","spread":"54.3"},{"groupId":"OG004","value":"2080","spread":"100.8"}]}]},{"title":"Day 15","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"4"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"179","spread":"NA","comment":"Insufficient data values to calculate coefficient of variation."},{"groupId":"OG001","value":"282","spread":"100.7"},{"groupId":"OG002","value":"1016","spread":"39.2"},{"groupId":"OG003","value":"1351","spread":"45.0"},{"groupId":"OG004","value":"1900","spread":"93.5"}]}]}]},{"type":"PRIMARY","title":"Area Under the Concentration Time-Curve From 0-24 Hours After a Dose (AUC0-24) for CC-223","description":"AUC0-24 is defined as the area under the concentration-time curve from Time 0 to 24 hours after a dose. Plasma CC-223 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL.","populationDescription":"All treated participants with available pharmacokinetic data in Part A.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"Geometric Coefficient of Variation","unitOfMeasure":"ng*h/mL","timeFrame":"0 to 24 hours post-dose on Day -1 and Day 15","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"classes":[{"title":"Day -1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"319","spread":"NA","comment":"Insufficient data values to calculate coefficient of variation."},{"groupId":"OG001","value":"379","spread":"45.2"},{"groupId":"OG002","value":"1144","spread":"36.5"},{"groupId":"OG003","value":"1497","spread":"45.5"},{"groupId":"OG004","value":"2031","spread":"96.3"}]}]},{"title":"Day 15","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"4"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"299","spread":"NA","comment":"Insufficient data values to calculate coefficient of variation."},{"groupId":"OG001","value":"383","spread":"88.8"},{"groupId":"OG002","value":"1443","spread":"41.4"},{"groupId":"OG003","value":"2082","spread":"29.3"},{"groupId":"OG004","value":"2954","spread":"106.2"}]}]}]},{"type":"PRIMARY","title":"Area Under the Plasma Concentration-Time Curve From Time 0 Extrapolated to Infinity (AUCinf) For CC-223","description":"AUCinf is defined as the area under the concentration-time curve from Time 0 extrapolated to infinity. Plasma CC-223 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. AUCinf was not assessed following multiple dosing as the blood sampling schedule on Day 15 did not allow robust assessment of the terminal elimination rate constant.","populationDescription":"All treated participants with available pharmacokinetic data in Part A.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"Geometric Coefficient of Variation","unitOfMeasure":"ng*h/mL","timeFrame":"Cycle 1 Day 1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose and Day 15: pre-dose, 0.5, 1, 1.5, 3, 5, and 8 hours post-dose","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"6"}]}],"classes":[{"title":"Day -1/1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"6"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"353","spread":"NA","comment":"Insufficient data values to calculate coefficient of variation."},{"groupId":"OG001","value":"378","spread":"49.7"},{"groupId":"OG002","value":"1234","spread":"38.9"},{"groupId":"OG003","value":"1694","spread":"41.8"},{"groupId":"OG004","value":"2074","spread":"111.4"}]}]},{"title":"Day 15","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]}]},{"type":"PRIMARY","title":"Part A: Terminal Elimination Phase Half-Life (T1/2) of CC-223","description":"Plasma CC-223 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. T1/2 was not assessed following multiple dosing as the blood sampling schedule on Day 15 did not allow robust assessment of the terminal elimination rate constant.","populationDescription":"All treated participants with available pharmacokinetic data in Part A.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"Geometric Coefficient of Variation","unitOfMeasure":"Hours","timeFrame":"Cycle 1 Day -1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"6"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.68","spread":"NA","comment":"Insufficient data values to calculate coefficient of variation."},{"groupId":"OG001","value":"3.35","spread":"54.1"},{"groupId":"OG002","value":"5.57","spread":"38.4"},{"groupId":"OG003","value":"4.86","spread":"25.9"},{"groupId":"OG004","value":"5.64","spread":"16.7"}]}]}]},{"type":"PRIMARY","title":"Apparent Total Body Clearance (CL/F) of CC-223","description":"CL/F is defined as the apparent total body clearance when dosed orally, calculated as Dose/AUCinf. Plasma CC-223 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL.","populationDescription":"All treated participants with available pharmacokinetic data in Part A.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"Geometric Coefficient of Variation","unitOfMeasure":"L/h","timeFrame":"Cycle 1 Day 1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose and Day 15: pre-dose, 0.5, 1, 1.5, 3, 5, and 8 hours post-dose","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"6"}]}],"classes":[{"title":"Day -1/1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"6"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"21.2","spread":"NA","comment":"Insufficient data values to calculate coefficient of variation."},{"groupId":"OG001","value":"39.7","spread":"49.7"},{"groupId":"OG002","value":"24.3","spread":"38.9"},{"groupId":"OG003","value":"26.6","spread":"41.8"},{"groupId":"OG004","value":"28.9","spread":"111.4"}]}]},{"title":"Day 15","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"4"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"25.1","spread":"NA","comment":"Insufficient data values to calculate coefficient of variation."},{"groupId":"OG001","value":"39.2","spread":"88.8"},{"groupId":"OG002","value":"20.8","spread":"41.4"},{"groupId":"OG003","value":"21.6","spread":"29.3"},{"groupId":"OG004","value":"20.3","spread":"106.2"}]}]}]},{"type":"PRIMARY","title":"Apparent Volume of Distribution (Vz/F) of CC-223","description":"Plasma CC-223 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. VZ/F was not assessed following multiple dosing as the blood sampling schedule on Day 15 did not allow robust assessment of the terminal elimination rate constant.","populationDescription":"All treated participants with available pharmacokinetic data in Part A.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"Geometric Coefficient of Variation","unitOfMeasure":"L","timeFrame":"Cycle 1 Day -1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"6"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"235","spread":"NA","comment":"Insufficient data values to calculate coefficient of variation."},{"groupId":"OG001","value":"192","spread":"3.70"},{"groupId":"OG002","value":"195","spread":"36.7"},{"groupId":"OG003","value":"186","spread":"27.1"},{"groupId":"OG004","value":"236","spread":"107.5"}]}]}]},{"type":"SECONDARY","title":"Part A: Percent Change From Baseline in Levels of Phosphorylated Ribosomal Protein S6 (pS6RP) in Stimulated B Cells","description":"Phosphorylated S6RP is a biomarker for inhibition of the mammalian target of rapamycin complex 1 (mTORC1). Phosphorylated S6RP was measured in stimulated B cells via flow cytometry. The raw measurements were expressed as median fluorescence intensity (MFI). MFI values were normalized against calibration beads using a linear regression transformation carried out on a log-log scale and reported as equivalent reference fluorophores (ERF). The biomarker evaluable population included all subjects who took at least one dose of study drug and had at least one non-missing pharmacodynamic (PD) assessment. Results were not available for the single subject treated in the 7.5-mg dose group and for one of the two subjects treated in the 15-mg dose group.","populationDescription":"All biomarker evaluable participants who received treatment in Part A.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Full Range","unitOfMeasure":"Percent change","timeFrame":"Cycle 1 Day -1: 3 hours post-dose and Day 15: 1.5 hours post-dose","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"7"}]}],"classes":[{"title":"Day -1 3 hours post-dose","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"-19.4","lowerLimit":"-19.4","upperLimit":"-19.4"},{"groupId":"OG002","value":"-73.6","lowerLimit":"-86.1","upperLimit":"-58.5"},{"groupId":"OG003","value":"-79.8","lowerLimit":"-87.5","upperLimit":"-34.7"},{"groupId":"OG004","value":"-76.6","lowerLimit":"-83.4","upperLimit":"-60.2"}]}]},{"title":"Day 15 1.5 hours post-dose","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"4"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"174.0","lowerLimit":"174.0","upperLimit":"174.0"},{"groupId":"OG002","value":"-59.0","lowerLimit":"-77.5","upperLimit":"-41.3"},{"groupId":"OG003","value":"-80.5","lowerLimit":"-84.6","upperLimit":"-80.0"},{"groupId":"OG004","value":"-69.3","lowerLimit":"-86.2","upperLimit":"-61.7"}]}]}]},{"type":"SECONDARY","title":"Part A: Percent Change From Baseline in Levels of Phosphorylated Elongation I Initiation Binding Protein (p4E-BP1) in Stimulated T Cells","description":"Phosphorylated 4E-BP1 is a biomarker for inhibition of the mammalian target of rapamycin complex 1 (mTORC1). Phosphorylated 4E-BP1 was measured in stimulated T cells via flow cytometry. The raw measurements were expressed as median fluorescence intensity (MFI). MFI values were normalized against calibration beads using a linear regression transformation carried out on a log-log scale and reported as equivalent reference fluorophores (ERF). The biomarker evaluable population included all subjects who took at least one dose of study drug and had at least one non-missing pharmacodynamic (PD) assessment. Results were not available for the single subject treated in the 7.5-mg dose group and for one of the two subjects treated in the 15-mg dose group.","populationDescription":"All biomarker evaluable participants who received treatment in Part A.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Full Range","unitOfMeasure":"Percent change in p4E-BP1","timeFrame":"Cycle 1 Day -1: 3 hours post-dose and Day 15: 1.5 hours post-dose","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"7"}]}],"classes":[{"title":"Day -1 3 hours post-dose","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"-20.7","lowerLimit":"-20.7","upperLimit":"-20.7"},{"groupId":"OG002","value":"-44.0","lowerLimit":"-65.1","upperLimit":"-28.7"},{"groupId":"OG003","value":"-55.7","lowerLimit":"-71.2","upperLimit":"-26.4"},{"groupId":"OG004","value":"-44.3","lowerLimit":"-63.7","upperLimit":"-1.0"}]}]},{"title":"Day 15 1.5 hours post-dose","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"4"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"-14.4","lowerLimit":"-14.4","upperLimit":"-14.4"},{"groupId":"OG002","value":"-61.1","lowerLimit":"-92.8","upperLimit":"-44.5"},{"groupId":"OG003","value":"-54.8","lowerLimit":"-61.8","upperLimit":"-34.4"},{"groupId":"OG004","value":"-46.4","lowerLimit":"-69.8","upperLimit":"-26.3"}]}]}]},{"type":"SECONDARY","title":"Part A: Percent Change From Baseline in Levels of Phosphorylated Protein Kinase B (pAKT) in Stimulated Monocytes","description":"Phosphorylated AKT is a biomarker for inhibition of the mammalian target of rapamycin complex 2 (mTORC2). Phosphorylated AKT was measured in stimulated monocytes via flow cytometry. The raw measurements were expressed as median fluorescence intensity (MFI). MFI values were normalized against calibration beads using a linear regression transformation carried out on a log-log scale and reported as equivalent reference fluorophores (ERF). The biomarker evaluable population included all subjects who took at least one dose of study drug and had at least one non-missing pharmacodynamic (PD) assessment. Results were not available for the single subject treated in the 7.5-mg dose group and for one of the two subjects treated in the 15-mg dose group.","populationDescription":"All biomarker evaluable participants who received treatment in Part A.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Full Range","unitOfMeasure":"Percent change in pAKT","timeFrame":"Cycle 1 Day -1: 3 hours post-dose and Day 15: 1.5 hours post-dose","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"7"}]}],"classes":[{"title":"Day -1 3 hours post-dose","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"-26.9","lowerLimit":"-26.9","upperLimit":"-26.9"},{"groupId":"OG002","value":"-56.5","lowerLimit":"-72.2","upperLimit":"-31.7"},{"groupId":"OG003","value":"-59.7","lowerLimit":"-74.6","upperLimit":"-23.0"},{"groupId":"OG004","value":"-48.4","lowerLimit":"-53.6","upperLimit":"-26.7"}]}]},{"title":"Day 15 1.5 hours post-dose","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"4"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"58.3","lowerLimit":"58.3","upperLimit":"58.3"},{"groupId":"OG002","value":"-70.5","lowerLimit":"-81.1","upperLimit":"-39.6"},{"groupId":"OG003","value":"-55.8","lowerLimit":"-70.1","upperLimit":"-42.0"},{"groupId":"OG004","value":"-45.7","lowerLimit":"-56.5","upperLimit":"-31.6"}]}]}]},{"type":"SECONDARY","title":"Part B: Percent Change From Baseline in p4E-BP1 in Monocytes by Tumor Cohort","description":"Phosphorylated 4E-BP1 is a biomarker for inhibition of the mammalian target of rapamycin complex 1 (mTORC1). Phosphorylated 4E-BP1 was measured in stimulated monocytes via flow cytometry. MFI values were determined and converted to molecules of equivalent fluorescence label (MEFL) by normalizing against calibration beads. The biomarker evaluable population included all subjects who took at least one dose of study drug and had at least one non-missing pharmacodynamic (PD) assessment. Data is reported by T-cell subsets known as clusters of differentiation (CD).","populationDescription":"All biomarker evaluable participants who received treatment in Part B.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Full Range","unitOfMeasure":"Percent change in p4E-BP1","timeFrame":"Cycle 1 Day 1: 1.5 hours post-dose and Day 15: 1.5 hours post-dose","groups":[{"id":"OG000","title":"Part B: Glioblastoma Multiforme (GBM)","description":"Participants with GBM received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part B: Hepatocellular Carcinoma (HCC)","description":"Participants with HCC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part B: Neuroendocrine Tumor (NET)","description":"Participants with NET received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part B: Diffuse Large B-cell Lymphoma (DLBCL)","description":"Participants with DLBCL received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part B: Hormone Receptor Positive Breast Cancer (HRPBC)","description":"Participants with HRPBC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG005","title":"Part B: Non-small Cell Lung Cancer (NSCLC)","description":"Participants with NSCLC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG006","title":"Part B: Multiple Myeloma (MM)","description":"Participants with MM received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"44"},{"groupId":"OG002","value":"34"},{"groupId":"OG003","value":"15"},{"groupId":"OG004","value":"6"},{"groupId":"OG005","value":"18"},{"groupId":"OG006","value":"3"}]}],"classes":[{"title":"Day 1,1.5 hours post-dose - CD3+","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"24"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"15"},{"groupId":"OG004","value":"6"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"-23.5","lowerLimit":"-100.0","upperLimit":"157.1"},{"groupId":"OG002","value":"-50.0","lowerLimit":"-93.6","upperLimit":"114.3"},{"groupId":"OG003","value":"-61.6","lowerLimit":"-100.0","upperLimit":"19.8"},{"groupId":"OG004","value":"-63.3","lowerLimit":"-93.8","upperLimit":"122.5"}]}]},{"title":"Day 15, 1.5 hours post-dose - CD3+","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"22"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"-38.9","lowerLimit":"-100.0","upperLimit":"445.8"},{"groupId":"OG002","value":"-51.8","lowerLimit":"-98.9","upperLimit":"105.0"},{"groupId":"OG003","value":"-58.7","lowerLimit":"-100.0","upperLimit":"42.1"},{"groupId":"OG004","value":"-58.4","lowerLimit":"-100.0","upperLimit":"79.3"}]}]},{"title":"Day 1,1.5 hours post-dose - CD14+","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"44"},{"groupId":"OG002","value":"34"},{"groupId":"OG003","value":"15"},{"groupId":"OG004","value":"6"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-28.7","lowerLimit":"-28.7","upperLimit":"-28.7"},{"groupId":"OG001","value":"-17.3","lowerLimit":"-87.0","upperLimit":"66.6"},{"groupId":"OG002","value":"-11.7","lowerLimit":"-85.3","upperLimit":"46.3"},{"groupId":"OG003","value":"-44.5","lowerLimit":"-85.1","upperLimit":"438.9"},{"groupId":"OG004","value":"-49.4","lowerLimit":"-68.4","upperLimit":"31.7"}]}]},{"title":"Day 15, 1.5 hours post-dose - CD14+","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"19"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-61.3","lowerLimit":"-61.3","upperLimit":"-61.3"},{"groupId":"OG001","value":"-58.1","lowerLimit":"-91.7","upperLimit":"528.1"},{"groupId":"OG002","value":"-39.1","lowerLimit":"-78.7","upperLimit":"26.0"},{"groupId":"OG003","value":"-74.1","lowerLimit":"-94.1","upperLimit":"210.2"},{"groupId":"OG004","value":"-35.8","lowerLimit":"-70.0","upperLimit":"154.7"}]}]},{"title":"Day 1,1.5 hours post-dose - CD19+","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"25"},{"groupId":"OG002","value":"34"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"6"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-15.3","lowerLimit":"-15.3","upperLimit":"-15.3"},{"groupId":"OG001","value":"-44.3","lowerLimit":"-100.0","upperLimit":"266.7"},{"groupId":"OG002","value":"-39.4","lowerLimit":"-93.7","upperLimit":"34.3"},{"groupId":"OG003","value":"-44.5","lowerLimit":"-71.9","upperLimit":"-36.0"},{"groupId":"OG004","value":"-44.8","lowerLimit":"-88.3","upperLimit":"58.2"}]}]},{"title":"Day 15, 1.5 hours post-dose - CD19+","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.3","lowerLimit":"-0.3","upperLimit":"-0.3"},{"groupId":"OG001","value":"-48.0","lowerLimit":"-91.0","upperLimit":"844.4"},{"groupId":"OG002","value":"-51.1","lowerLimit":"-86.1","upperLimit":"18.1"},{"groupId":"OG003","value":"-27.3","lowerLimit":"-32.7","upperLimit":"-5.0"},{"groupId":"OG004","value":"-12.0","lowerLimit":"-77.2","upperLimit":"229.7"}]}]},{"title":"Day 1,1.5 hours post-dose - CD91+","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"16"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"2"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"18"},{"groupId":"OG006","value":"3"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-39.4","lowerLimit":"-69.2","upperLimit":"20.1"},{"groupId":"OG001","value":"-20.0","lowerLimit":"-58.1","upperLimit":"8.3"},{"groupId":"OG002","value":"-49.4","lowerLimit":"-63.7","upperLimit":"-13.2"},{"groupId":"OG003","value":"-24.5","lowerLimit":"-32.4","upperLimit":"-16.6"},{"groupId":"OG004","value":"-43.0","lowerLimit":"-43.0","upperLimit":"-43.0"},{"groupId":"OG005","value":"-24.9","lowerLimit":"-57.6","upperLimit":"28.1"},{"groupId":"OG006","value":"-51.4","lowerLimit":"-64.2","upperLimit":"-25.1"}]}]},{"title":"Day 15, 1.5 hours post-dose - CD91+","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"44"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"9"},{"groupId":"OG006","value":"2"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-22.4","lowerLimit":"-53.7","upperLimit":"151.3"},{"groupId":"OG001","value":"-24.7","lowerLimit":"-39.7","upperLimit":"16.8"},{"groupId":"OG003","value":"-6.9","lowerLimit":"-6.9","upperLimit":"-6.9"},{"groupId":"OG005","value":"-24.8","lowerLimit":"-38.4","upperLimit":"77.5"},{"groupId":"OG006","value":"19.6","lowerLimit":"-7.9","upperLimit":"47.2"}]}]}]},{"type":"SECONDARY","title":"Part B: Percent Change From Baseline in p4E-BP1 in Monocytes in the HCC and NET Cohorts by Dose","description":"Phosphorylated 4E-BP1 is a biomarker for inhibition of the mammalian target of rapamycin complex 1 (mTORC1). Phosphorylated 4E-BP1 was measured in stimulated monocytes via flow cytometry. MFI values were determined and converted to molecules of equivalent fluorescence label (MEFL) by normalizing against calibration beads. The biomarker evaluable population included all subjects who took at least one dose of study drug and had at least one non-missing pharmacodynamic (PD) assessment. Data is reported by T-cell subsets known as clusters of differentiation (CD).","populationDescription":"All biomarker evaluable participants who received treatment in Part B.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Full Range","unitOfMeasure":"Percent change in p4E-BP1","timeFrame":"Cycle 1 Day 1: 1.5 hours post-dose and Day 15: 1.5 hours post-dose","groups":[{"id":"OG000","title":"HCC 30 mg","description":"Participants with HCC received a daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"HCC 45 mg","description":"Participants with HCC received a daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"NET 30 mg","description":"Participants with NET received a daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"NET 45 mg","description":"Participants with NET received a daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"13"}]}],"classes":[{"title":"Day 1 1.5 hours post-dose - CD3+","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"12"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-28.3","lowerLimit":"-100.0","upperLimit":"127.6"},{"groupId":"OG001","value":"20.0","lowerLimit":"-69.1","upperLimit":"157.1"},{"groupId":"OG002","value":"-40.4","lowerLimit":"-93.6","upperLimit":"11.6"},{"groupId":"OG003","value":"-70.6","lowerLimit":"-90.0","upperLimit":"114.3"}]}]},{"title":"Day 15 1.5 hours post-dose - CD3+","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"15"},{"groupId":"OG003","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-34.0","lowerLimit":"-100.0","upperLimit":"445.8"},{"groupId":"OG001","value":"-52.8","lowerLimit":"-62.6","upperLimit":"52.4"},{"groupId":"OG002","value":"-39.7","lowerLimit":"-95.7","upperLimit":"33.8"},{"groupId":"OG003","value":"-70.2","lowerLimit":"-98.9","upperLimit":"105.0"}]}]},{"title":"Day 1 1.5 hours post-dose - CD14+","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"13"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-22.1","lowerLimit":"-87.0","upperLimit":"28.9"},{"groupId":"OG001","value":"7.0","lowerLimit":"-50.6","upperLimit":"66.6"},{"groupId":"OG002","value":"-8.7","lowerLimit":"-54.7","upperLimit":"25.8"},{"groupId":"OG003","value":"-36.6","lowerLimit":"-85.3","upperLimit":"46.3"}]}]},{"title":"Day 15 1.5 hours post-dose - CD14+","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"15"},{"groupId":"OG003","value":"8"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-58.1","lowerLimit":"-91.7","upperLimit":"528.1"},{"groupId":"OG001","value":"-28.4","lowerLimit":"-67.5","upperLimit":"111.6"},{"groupId":"OG002","value":"-25.6","lowerLimit":"-78.7","upperLimit":"26.0"},{"groupId":"OG003","value":"-47.4","lowerLimit":"-68.3","upperLimit":"23.2"}]}]}]},{"type":"SECONDARY","title":"Part B: Percent Change From Baseline in Levels of pAKT in Monocytes by Tumor Cohort","description":"Phosphorylated AKT is a biomarker for inhibition of the mammalian target of rapamycin complex 2 (mTORC2). Phosphorylated AKT was measured in stimulated monocytes via flow cytometry. MFI values were determined and converted to molecules of equivalent fluorescence label (MEFL) by normalizing against calibration beads. The biomarker evaluable population included all subjects who took at least one dose of study drug and had at least one non-missing pharmacodynamic (PD) assessment.","populationDescription":"All biomarker evaluable participants who received treatment in Part B.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Full Range","unitOfMeasure":"Percent change in pAKT","timeFrame":"Cycle 1 Day 1: 1.5 hours post-dose and Day 15: 1.5 hours post-dose","groups":[{"id":"OG000","title":"Part B: Non-small Cell Lung Cancer (NSCLC)","description":"Participants with NSCLC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part B: Glioblastoma Multiforme (GBM)","description":"Participants with GBM received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part B: Hepatocellular Carcinoma (HCC)","description":"Participants with HCC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part B: Neuroendocrine Tumor (NET)","description":"Participants with NET received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part B: Diffuse Large B-cell Lymphoma (DLBCL)","description":"Participants with DLBCL received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG005","title":"Part B: Multiple Myeloma (MM)","description":"Participants with MM received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG006","title":"Part B: Hormone Receptor Positive Breast Cancer (HRPBC)","description":"Participants with HRPBC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"16"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"4"},{"groupId":"OG006","value":"1"}]}],"classes":[{"title":"Day 1 1.5 hours post-dose","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"16"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"4"},{"groupId":"OG006","value":"1"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-68.1","lowerLimit":"-86.5","upperLimit":"43.9"},{"groupId":"OG001","value":"-28.0","lowerLimit":"-73.0","upperLimit":"130.1"},{"groupId":"OG002","value":"-55.5","lowerLimit":"-86.2","upperLimit":"27.1"},{"groupId":"OG003","value":"-70.3","lowerLimit":"-83.7","upperLimit":"-51.2"},{"groupId":"OG004","value":"-54.3","lowerLimit":"-89.0","upperLimit":"-19.6"},{"groupId":"OG005","value":"-78.8","lowerLimit":"-86.2","upperLimit":"-27.1"},{"groupId":"OG006","value":"-53.8","lowerLimit":"-53.8","upperLimit":"-53.8"}]}]},{"title":"Day 15 1.5 hours post-dose","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"2"},{"groupId":"OG006","value":"0"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-76.1","lowerLimit":"-93.0","upperLimit":"-27.5"},{"groupId":"OG001","value":"-34.1","lowerLimit":"-89.8","upperLimit":"48.6"},{"groupId":"OG002","value":"-84.1","lowerLimit":"-87.7","upperLimit":"-19.5"},{"groupId":"OG003","value":"-52.2","lowerLimit":"-52.2","upperLimit":"-52.2"},{"groupId":"OG004","value":"-88.6","lowerLimit":"-88.6","upperLimit":"-88.6"},{"groupId":"OG005","value":"-52.9","lowerLimit":"-77.5","upperLimit":"-28.2"}]}]}]},{"type":"SECONDARY","title":"Part B: Percent Change From Baseline in Levels of pAKT in Monocytes in the HCC and NET Cohorts by Dose","description":"Phosphorylated AKT is a biomarker for inhibition of the mammalian target of rapamycin complex 2 (mTORC2). Phosphorylated AKT was measured in stimulated monocytes via flow cytometry. MFI values were determined and converted to molecules of equivalent fluorescence label (MEFL) by normalizing against calibration beads. The biomarker evaluable population included all subjects who took at least one dose of study drug and had at least one non-missing pharmacodynamic (PD) assessment.","populationDescription":"All biomarker evaluable participants who received treatment in Part B.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Full Range","unitOfMeasure":"Percent change in pAKT","timeFrame":"Cycle 1 Day 1: 1.5 hours post-dose and Day 15: 1.5 hours post-dose","groups":[{"id":"OG000","title":"HCC 30mg","description":"Participants with HCC received a daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"HCC 45mg","description":"Participants with HCC received a daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"NET 30mg","description":"Participants with NET received a daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"NET 45mg","description":"Participants with NET received a daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"16"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"4"}]}],"classes":[{"title":"Day 1 1.5 hours post-dose","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"16"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"4"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"-55.5","lowerLimit":"-86.2","upperLimit":"27.1"},{"groupId":"OG003","value":"-70.3","lowerLimit":"-83.7","upperLimit":"-51.2"}]}]},{"title":"Day 15 1.5 hours post-dose","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"-84.1","lowerLimit":"-87.7","upperLimit":"-19.5"},{"groupId":"OG003","value":"-52.2","lowerLimit":"-52.2","upperLimit":"-52.2"}]}]}]},{"type":"SECONDARY","title":"Part B: Percent Change From Baseline in pS6RP Levels in Tumor Tissue by Tumor Type","description":"Tumor tissue biopsies were performed at Baseline and on Day 15 3 hours post dose. Levels of pS6RP were quantified using immunohistochemical (IHC) methods.","populationDescription":"All biomarker evaluable participants who received treatment in Part B.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Full Range","unitOfMeasure":"Percent change in pS6RP","timeFrame":"Up to Cycle 1 Day 15 3 hours post dose","groups":[{"id":"OG000","title":"Part B: Non-small Cell Lung Cancer (NSCLC)","description":"Participants with NSCLC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part B: Glioblastoma Multiforme (GBM)","description":"Participants with GBM received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part B: Hepatocellular Carcinoma (HCC)","description":"Participants with HCC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part B: Neuroendocrine Tumor (NET)","description":"Participants with NET received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part B: Diffuse Large B-cell Lymphoma (DLBCL)","description":"Participants with DLBCL received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG005","title":"Part B: Multiple Myeloma (MM)","description":"Participants with MM received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG006","title":"Part B: Hormone Receptor Positive Breast Cancer (HRPBC)","description":"Participants with HRPBC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"9"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"3"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22","spread":"-37","lowerLimit":"-37","upperLimit":"66"},{"groupId":"OG001","value":"-36","spread":"-36","lowerLimit":"-36","upperLimit":"-36"},{"groupId":"OG002","value":"-19","spread":"-37","lowerLimit":"-37","upperLimit":"24"},{"groupId":"OG003","value":"-30","spread":"-30","lowerLimit":"-30","upperLimit":"-30"},{"groupId":"OG004","value":"-21","spread":"-43","lowerLimit":"-43","upperLimit":"12"},{"groupId":"OG006","value":"-15","spread":"-17","lowerLimit":"-17","upperLimit":"6"}]}]}]},{"type":"SECONDARY","title":"Part A: Overall Response Rate","description":"Tumor response was based on Investigator assessment according to Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 for solid tumors (NSCLC, HCC, NET, and HRPBC), and the International Working Group Criteria (IWC) for DLBCL. Overall Response Rate is defined as the percentage of participants with a best overall response of complete response or partial response. Complete response is defined as the disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to \\<10 mm. Partial response is defined as at least a 30% decrease in the sum of diameters of target lesions, taking as reference the baseline sum diameters. In Part A, participants with MM and participants with GBM were not evaluated for tumor response.","populationDescription":"Participants who received treatment in Part A","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"90% Confidence Interval","unitOfMeasure":"Percentage of participants","timeFrame":"From first dose up to tumor response (approximately 11 months)","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0","lowerLimit":"NA","upperLimit":"NA","comment":"Lower and upper limit not calculated due to insufficient number of events"},{"groupId":"OG002","value":"11.1","lowerLimit":"0.6","upperLimit":"42.9"},{"groupId":"OG003","value":"0","lowerLimit":"NA","upperLimit":"NA","comment":"Lower and upper limit not calculated due to insufficient number of events"},{"groupId":"OG004","value":"0","lowerLimit":"NA","upperLimit":"NA","comment":"Lower and upper limit not calculated due to insufficient number of events"}]}]}]},{"type":"SECONDARY","title":"Part B: Overall Response Rate","description":"Tumor response was based on Investigator assessment according to Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 for solid tumors (NSCLC, HCC, NET, and HRPBC), International Working Group Criteria (IWC) for DLBCL, and the International Myeloma Working Group (IMWG) criteria for MM. For GBM, Responses Assessment for Neuro-Oncology Working Group (RANO) criteria were used for tumor response, using the post resection MRI scan as the baseline. Overall Response Rate is defined as the percentage of participants with a best overall response of complete response or partial response. Complete response is defined as the disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to \\<10 mm. Partial response is defined as at least a 30% decrease in the sum of diameters of target lesions, taking as reference the baseline sum diameters.","populationDescription":"Participants who received treatment in Part B reported by tumor cohort","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Percentage of participants","timeFrame":"From first dose up to tumor response (approximately 36 months)","groups":[{"id":"OG000","title":"Part B: Non-small Cell Lung Cancer (NSCLC)","description":"Participants with NSCLC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part B: Glioblastoma Multiforme (GBM)","description":"Participants with GBM received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part B: Hepatocellular Carcinoma (HCC)","description":"Participants with HCC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part B: Neuroendocrine Tumor (NET)","description":"Participants with NET received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part B: Diffuse Large B-cell Lymphoma (DLBCL)","description":"Participants with DLBCL received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG005","title":"Part B: Multiple Myeloma (MM)","description":"Participants with MM received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG006","title":"Part B: Hormone Receptor Positive Breast Cancer (HRPBC)","description":"Participants with HRPBC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"53"},{"groupId":"OG003","value":"47"},{"groupId":"OG004","value":"28"},{"groupId":"OG005","value":"14"},{"groupId":"OG006","value":"17"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.8","lowerLimit":"0.1","upperLimit":"19.6"},{"groupId":"OG001","value":"0","lowerLimit":"NA","upperLimit":"NA","comment":"Lower and upper limit not calculated due to insufficient number of events"},{"groupId":"OG002","value":"5.7","lowerLimit":"1.2","upperLimit":"15.7"},{"groupId":"OG003","value":"6.4","lowerLimit":"1.3","upperLimit":"17.5"},{"groupId":"OG004","value":"10.7","lowerLimit":"2.3","upperLimit":"28.2"},{"groupId":"OG005","value":"0","lowerLimit":"NA","upperLimit":"NA","comment":"Lower and upper limit not calculated due to insufficient number of events"},{"groupId":"OG006","value":"11.8","lowerLimit":"1.5","upperLimit":"36.4"}]}]}]},{"type":"SECONDARY","title":"Maximum Observed Concentration (Cmax) of Metabolite M1","description":"Cmax is defined as the maximum observed concentration (in plasma), obtained directly from the observed concentration versus time data. Plasma metabolite M1 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 10.0 ng/mL.","populationDescription":"All treated participants with available pharmacokinetic data in Part A.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"Geometric Coefficient of Variation","unitOfMeasure":"ng/mL","timeFrame":"Cycle 1 Day -1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose and Day 15: pre-dose, 0.5, 1, 1.5, 3, 5, and 8 hours post-dose","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"classes":[{"title":"Day -1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"143","spread":"NA","comment":"Insufficient data values to calculate coefficient of variation."},{"groupId":"OG001","value":"284","spread":"64.6"},{"groupId":"OG002","value":"729","spread":"40.3"},{"groupId":"OG003","value":"1002","spread":"37.2"},{"groupId":"OG004","value":"1174","spread":"86.0"}]}]},{"title":"Day 15","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"7"},{"groupId":"OG004","value":"5"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"363","spread":"NA","comment":"Insufficient data values to calculate coefficient of variation."},{"groupId":"OG001","value":"357","spread":"139.8"},{"groupId":"OG002","value":"1681","spread":"34.5"},{"groupId":"OG003","value":"2061","spread":"23.1"},{"groupId":"OG004","value":"1946","spread":"78.9"}]}]}]},{"type":"SECONDARY","title":"Time to Maximum Concentration (Tmax) of Metabolite M1","description":"Tmax is defined as the time to Cmax, obtained directly from the observed concentration versus time data. Plasma metabolite M1 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 10.0 ng/mL.","populationDescription":"All treated participants with available pharmacokinetic data in Part A.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Full Range","unitOfMeasure":"Hours","timeFrame":"Cycle 1 Day -1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose and Day 15: pre-dose, 0.5, 1, 1.5, 3, 5, and 8 hours post-dose","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"classes":[{"title":"Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8.00","lowerLimit":"8.00","upperLimit":"8.00"},{"groupId":"OG001","value":"2.28","lowerLimit":"1.50","upperLimit":"3.05"},{"groupId":"OG002","value":"6.51","lowerLimit":"1.50","upperLimit":"8.00"},{"groupId":"OG003","value":"5.00","lowerLimit":"1.60","upperLimit":"8.00"},{"groupId":"OG004","value":"5.00","lowerLimit":"1.67","upperLimit":"8.00"}]}]},{"title":"Day 15","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"7"},{"groupId":"OG004","value":"5"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1.50","lowerLimit":"1.50","upperLimit":"1.50"},{"groupId":"OG001","value":"3.25","lowerLimit":"1.50","upperLimit":"5.00"},{"groupId":"OG002","value":"1.58","lowerLimit":"1.00","upperLimit":"3.03"},{"groupId":"OG003","value":"1.71","lowerLimit":"0.00","upperLimit":"3.20"},{"groupId":"OG004","value":"3.00","lowerLimit":"0.00","upperLimit":"5.00"}]}]}]},{"type":"SECONDARY","title":"Area Under the Plasma Concentration-Time Curve From Time 0 to the Last Measurable Concentration (AUCt) for Metabolite M1","description":"AUCt is defined as the area under the concentration-time curve from Time 0 to the time of the last quantifiable concentration. Plasma metabolite M1 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 10.0 ng/mL.","populationDescription":"All treated participants with available pharmacokinetic data in Part A.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"Geometric Coefficient of Variation","unitOfMeasure":"ng*h/mL","timeFrame":"Cycle 1 Day -1: pre-dose, 0.5, 1, 1.5, 3, 5, 8, 24 and 48 hours post-dose and Day 15: pre-dose, 0.5, 1, 1.5, 3, 5, and 8 hours post-dose","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"classes":[{"title":"Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4583","spread":"NA","comment":"Insufficient data values to calculate coefficient of variation."},{"groupId":"OG001","value":"3788","spread":"121.2"},{"groupId":"OG002","value":"18964","spread":"45.1"},{"groupId":"OG003","value":"19938","spread":"30.1"},{"groupId":"OG004","value":"23702","spread":"98.1"}]}]},{"title":"Day 15","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"7"},{"groupId":"OG004","value":"5"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6401","spread":"NA","comment":"Insufficient data values to calculate coefficient of variation."},{"groupId":"OG001","value":"4388","spread":"133.8"},{"groupId":"OG002","value":"27389","spread":"48.5"},{"groupId":"OG003","value":"30823","spread":"38.3"},{"groupId":"OG004","value":"33070","spread":"101.6"}]}]}]},{"type":"SECONDARY","title":"Area Under the Concentration Time-Curve From 0-24 Hours After a Dose (AUC0-24) for Metabolite M1","description":"AUC0-24 is defined as the area under the concentration-time curve from Time 0 to 24 hours after a dose. Plasma metabolite M1 was measured using validated chiral liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 10.0 ng/mL.","populationDescription":"All treated participants with available pharmacokinetic data in Part A.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"Geometric Coefficient of Variation","unitOfMeasure":"ng*h/mL","timeFrame":"0 to 24 hours post-dose on Day -1 and Day 15","groups":[{"id":"OG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."},{"id":"OG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"classes":[{"title":"Day 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2712","spread":"NA","comment":"Insufficient data values to calculate coefficient of variation."},{"groupId":"OG001","value":"3207","spread":"82.5"},{"groupId":"OG002","value":"12328","spread":"39.4"},{"groupId":"OG003","value":"14107","spread":"26.9"},{"groupId":"OG004","value":"16926","spread":"89.2"}]}]},{"title":"Day 15","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"7"},{"groupId":"OG004","value":"5"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6401","spread":"NA","comment":"Insufficient data values to calculate coefficient of variation."},{"groupId":"OG001","value":"4388","spread":"133.8"},{"groupId":"OG002","value":"27389","spread":"48.5"},{"groupId":"OG003","value":"30823","spread":"38.3"},{"groupId":"OG004","value":"33070","spread":"101.6"}]}]}]},{"type":"PRIMARY","title":"Part B: Progression Free Survival (PFS) Rate at 6 Months for GBM Participants","description":"Progression free survival rate of GBM participants at 6 months is defined as the percentage of participants without progressive disease per Evaluation Criteria in Solid Tumors (RECIST) 1.1 6 months after starting study treatment. Progressive disease is defined as the appearance of one or more new lesions and/or unequivocal progression of existing non-target lesions.","populationDescription":"All treated participants in Part B with GBM without progression per RECIST 1.0 at 6 months","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Percentage of participants","timeFrame":"From first dose to 6 months","groups":[{"id":"OG000","title":"Part B: Glioblastoma Multiforme (GBM)","description":"Participants with GBM received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"13"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"NA","upperLimit":"NA","comment":"Lower and upper limit not reached to insufficient number of events"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"All-Cause Mortality: From first dose through the course of the trial (up to approximately 6 years). Part A SAEs and AEs: From first dose to 100 days post last dose (up to approximately 14 months). Part B SAEs and AEs: From first dose to 100 days post last dose (up to approximately 49 months).","description":"Although the protocol stated Part B participants would begin treatment at the MTD determined by Part A (45 mg), the conduct of Part B permitted participants to stay in the study even though they had many dose reductions and dosing interruptions. Dosing/exposure for participants varied greatly and there were few participants which remained at any given dose for most of the study. Due to this, there was no analysis of Part B data available according to dose.","eventGroups":[{"id":"EG000","title":"Part A: CC-223 7.5 mg","description":"Participants received a single dose of 7.5 mg CC-223 on Day -1, then daily dosing of 7.5 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator.","deathsNumAffected":0,"deathsNumAtRisk":1,"seriousNumAffected":0,"seriousNumAtRisk":1,"otherNumAffected":1,"otherNumAtRisk":1},{"id":"EG001","title":"Part A: CC-223 15 mg","description":"Participants received a single dose of 15 mg CC-223 on Day -1, then daily dosing of 15 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator.","deathsNumAffected":0,"deathsNumAtRisk":2,"seriousNumAffected":0,"seriousNumAtRisk":2,"otherNumAffected":2,"otherNumAtRisk":2},{"id":"EG002","title":"Part A: CC-223 30 mg","description":"Participants received a single dose of 30 mg CC-223 on Day -1, then daily dosing of 30 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator.","deathsNumAffected":2,"deathsNumAtRisk":9,"seriousNumAffected":4,"seriousNumAtRisk":9,"otherNumAffected":8,"otherNumAtRisk":9},{"id":"EG003","title":"Part A: CC-223 45 mg","description":"Participants received a single dose of 45 mg CC-223 on Day -1, then daily dosing of 45 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator.","deathsNumAffected":3,"deathsNumAtRisk":9,"seriousNumAffected":4,"seriousNumAtRisk":9,"otherNumAffected":9,"otherNumAtRisk":9},{"id":"EG004","title":"Part A: CC-223 60 mg","description":"Participants received a single dose of 60 mg CC-223 on Day -1, then daily dosing of 60 mg CC-223 for 28 days beginning on Day 1. Participants received subsequent cycles consisting of 28-day continuous dosing without rest between cycles for as long as they derived benefit from treatment as judged by the investigator.","deathsNumAffected":1,"deathsNumAtRisk":7,"seriousNumAffected":2,"seriousNumAtRisk":7,"otherNumAffected":7,"otherNumAtRisk":7},{"id":"EG005","title":"Part B: Non-small Cell Lung Cancer (NSCLC)","description":"Participants with NSCLC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator.","deathsNumAffected":10,"deathsNumAtRisk":26,"seriousNumAffected":15,"seriousNumAtRisk":26,"otherNumAffected":26,"otherNumAtRisk":26},{"id":"EG006","title":"Part B: Glioblastoma Multiforme (GBM)","description":"Participants with GBM received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator.","deathsNumAffected":3,"deathsNumAtRisk":13,"seriousNumAffected":6,"seriousNumAtRisk":13,"otherNumAffected":13,"otherNumAtRisk":13},{"id":"EG007","title":"Part B: Hepatocellular Carcinoma (HCC)","description":"Participants with HCC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator.","deathsNumAffected":24,"deathsNumAtRisk":53,"seriousNumAffected":29,"seriousNumAtRisk":53,"otherNumAffected":53,"otherNumAtRisk":53},{"id":"EG008","title":"Part B: Neuroendocrine Tumor (NET)","description":"Participants with NET received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator.","deathsNumAffected":2,"deathsNumAtRisk":47,"seriousNumAffected":23,"seriousNumAtRisk":47,"otherNumAffected":47,"otherNumAtRisk":47},{"id":"EG009","title":"Part B: Diffuse Large B-cell Lymphoma (DLBCL)","description":"Participants with DLBCL received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator.","deathsNumAffected":5,"deathsNumAtRisk":28,"seriousNumAffected":17,"seriousNumAtRisk":28,"otherNumAffected":28,"otherNumAtRisk":28},{"id":"EG010","title":"Part B: Multiple Myeloma (MM)","description":"Participants with MM received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator.","deathsNumAffected":2,"deathsNumAtRisk":14,"seriousNumAffected":6,"seriousNumAtRisk":14,"otherNumAffected":14,"otherNumAtRisk":14},{"id":"EG011","title":"Part B: Hormone Receptor Positive Breast Cancer (HRPBC)","description":"Participants with HRPBC received CC-223 at a starting dose of 45 mg/day (reduced to 30 mg/day after protocol Amendment 9) orally once a day in 28-day cycles for as long as they derived benefit from treatment as judged by the investigator.","deathsNumAffected":4,"deathsNumAtRisk":17,"seriousNumAffected":11,"seriousNumAtRisk":17,"otherNumAffected":17,"otherNumAtRisk":17}],"seriousEvents":[{"term":"Lymph node pain","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Neutropenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":1,"numAtRisk":17}]},{"term":"Atrial thrombosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Left ventricular dysfunction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Myocardial ischaemia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Pericardial effusion","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Supraventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":2,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":2,"numAffected":2,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Aphthous ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Ascites","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Autoimmune pancreatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Colonic obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Crohn's disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Dysphagia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Pancreatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Pancreatitis acute","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Peptic ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Retroperitoneal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Small intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":3,"numAffected":2,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":2,"numAffected":2,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Asthenia","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":2,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"General physical health deterioration","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":3,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Impaired healing","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Mucosal inflammation","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Non-cardiac chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":53},{"groupId":"EG008","numEvents":3,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Bile duct stenosis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Cholecystitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Cholelithiasis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Hepatocellular injury","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hypersensitivity","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Abdominal sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Brain abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Campylobacter infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Clostridium difficile infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Cystitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Hepatitis B","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Herpes simplex pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Incision site infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Lower respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Lung infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Meningitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Perihepatic abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Pneumococcal sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":7,"numAffected":4,"numAtRisk":53},{"groupId":"EG008","numEvents":2,"numAffected":2,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":5,"numAffected":4,"numAtRisk":53},{"groupId":"EG008","numEvents":2,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Septic shock","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":2,"numAffected":2,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Urosepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Accidental overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hip fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Subdural haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Ammonia increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Blood creatinine increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Decreased appetite","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":53},{"groupId":"EG008","numEvents":2,"numAffected":2,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Hyperglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Hypokalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Hyponatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hypophosphataemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Metabolic acidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Myositis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Metastases to central nervous system","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Non-small cell lung cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Tumour pain","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hepatic encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Peripheral motor neuropathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Spinal cord compression","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":4,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Confusional state","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Delusional disorder, persecutory type","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Mania","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Mental status changes","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Acute kidney injury","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":28},{"groupId":"EG010","numEvents":2,"numAffected":2,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Haematuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Renal failure","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":2,"numAffected":2,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Renal tubular necrosis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Alveolitis allergic","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":2,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Haemoptysis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Pleural effusion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Pneumonitis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Pneumothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Respiratory distress","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Dermatitis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Dermatitis acneiform","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Rash macular","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":1,"numAffected":1,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Rash maculo-papular","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Deep vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":53},{"groupId":"EG008","numEvents":1,"numAffected":1,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Jugular vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]}],"otherEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":12,"numAffected":8,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":5,"numAffected":5,"numAtRisk":53},{"groupId":"EG008","numEvents":3,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":9,"numAffected":8,"numAtRisk":28},{"groupId":"EG010","numEvents":24,"numAffected":7,"numAtRisk":14},{"groupId":"EG011","numEvents":10,"numAffected":5,"numAtRisk":17}]},{"term":"Eosinophilia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Iron deficiency anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Leukocytosis","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":3,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Leukopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":6,"numAffected":3,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Lymphopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":4,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Neutropenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":5,"numAffected":3,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":8,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":12,"numAffected":6,"numAtRisk":28},{"groupId":"EG010","numEvents":18,"numAffected":4,"numAtRisk":14},{"groupId":"EG011","numEvents":9,"numAffected":3,"numAtRisk":17}]},{"term":"Thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":3,"numAffected":2,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":7,"numAffected":4,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":30,"numAffected":16,"numAtRisk":53},{"groupId":"EG008","numEvents":14,"numAffected":5,"numAtRisk":47},{"groupId":"EG009","numEvents":23,"numAffected":11,"numAtRisk":28},{"groupId":"EG010","numEvents":29,"numAffected":7,"numAtRisk":14},{"groupId":"EG011","numEvents":9,"numAffected":6,"numAtRisk":17}]},{"term":"Angina pectoris","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Palpitations","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":4,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":4,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Pericardial effusion","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":3,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Ventricular arrhythmia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Ventricular extrasystoles","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Ventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Cerumen impaction","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Deafness","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Vertigo","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":2,"numAffected":2,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Adrenal insufficiency","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Goitre","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Hyperthyroidism","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Blindness unilateral","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Eye haemorrhage","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Eye pruritus","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Eyelid oedema","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Periorbital oedema","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Scintillating scotoma","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Vision blurred","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":2,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":5,"numAffected":5,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Visual acuity reduced","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Visual impairment","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Abdominal discomfort","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":4,"numAffected":4,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Abdominal distension","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":5,"numAffected":5,"numAtRisk":53},{"groupId":"EG008","numEvents":4,"numAffected":4,"numAtRisk":47},{"groupId":"EG009","numEvents":3,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Abdominal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":3,"numAffected":2,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":20,"numAffected":14,"numAtRisk":53},{"groupId":"EG008","numEvents":24,"numAffected":15,"numAtRisk":47},{"groupId":"EG009","numEvents":8,"numAffected":5,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":5,"numAffected":3,"numAtRisk":17}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":5,"numAffected":5,"numAtRisk":53},{"groupId":"EG008","numEvents":7,"numAffected":7,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Abdominal rigidity","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Aphthous ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":5,"numAffected":4,"numAtRisk":14},{"groupId":"EG011","numEvents":5,"numAffected":3,"numAtRisk":17}]},{"term":"Ascites","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":3,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":9,"numAffected":5,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":4,"numAffected":2,"numAtRisk":17}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":7},{"groupId":"EG005","numEvents":10,"numAffected":9,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":13,"numAffected":12,"numAtRisk":53},{"groupId":"EG008","numEvents":10,"numAffected":9,"numAtRisk":47},{"groupId":"EG009","numEvents":10,"numAffected":8,"numAtRisk":28},{"groupId":"EG010","numEvents":3,"numAffected":3,"numAtRisk":14},{"groupId":"EG011","numEvents":5,"numAffected":5,"numAtRisk":17}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":9},{"groupId":"EG003","numEvents":5,"numAffected":5,"numAtRisk":9},{"groupId":"EG004","numEvents":6,"numAffected":5,"numAtRisk":7},{"groupId":"EG005","numEvents":41,"numAffected":16,"numAtRisk":26},{"groupId":"EG006","numEvents":6,"numAffected":5,"numAtRisk":13},{"groupId":"EG007","numEvents":55,"numAffected":32,"numAtRisk":53},{"groupId":"EG008","numEvents":138,"numAffected":36,"numAtRisk":47},{"groupId":"EG009","numEvents":29,"numAffected":17,"numAtRisk":28},{"groupId":"EG010","numEvents":9,"numAffected":7,"numAtRisk":14},{"groupId":"EG011","numEvents":21,"numAffected":11,"numAtRisk":17}]},{"term":"Dry mouth","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":5,"numAffected":5,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":4,"numAffected":4,"numAtRisk":53},{"groupId":"EG008","numEvents":10,"numAffected":9,"numAtRisk":47},{"groupId":"EG009","numEvents":5,"numAffected":4,"numAtRisk":28},{"groupId":"EG010","numEvents":3,"numAffected":3,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Dyspepsia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Dysphagia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":8,"numAffected":5,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":4,"numAffected":4,"numAtRisk":53},{"groupId":"EG008","numEvents":3,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":3,"numAffected":2,"numAtRisk":17}]},{"term":"Flatulence","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":4,"numAffected":4,"numAtRisk":53},{"groupId":"EG008","numEvents":7,"numAffected":5,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Gastrooesophageal reflux disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":5,"numAffected":5,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":1,"numAtRisk":17}]},{"term":"Haematochezia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Haemorrhoids","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":8,"numAffected":7,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":3,"numAffected":3,"numAtRisk":17}]},{"term":"Lip dry","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Mouth haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Mouth ulceration","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":7,"numAffected":2,"numAtRisk":17}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":5,"numAffected":4,"numAtRisk":9},{"groupId":"EG003","numEvents":6,"numAffected":6,"numAtRisk":9},{"groupId":"EG004","numEvents":4,"numAffected":3,"numAtRisk":7},{"groupId":"EG005","numEvents":28,"numAffected":16,"numAtRisk":26},{"groupId":"EG006","numEvents":13,"numAffected":9,"numAtRisk":13},{"groupId":"EG007","numEvents":40,"numAffected":27,"numAtRisk":53},{"groupId":"EG008","numEvents":34,"numAffected":22,"numAtRisk":47},{"groupId":"EG009","numEvents":16,"numAffected":13,"numAtRisk":28},{"groupId":"EG010","numEvents":12,"numAffected":7,"numAtRisk":14},{"groupId":"EG011","numEvents":21,"numAffected":12,"numAtRisk":17}]},{"term":"Odynophagia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":3,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Oesophagitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Oral pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":4,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Proctalgia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":7,"numAffected":6,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Retching","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Small intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Stomatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":2,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":20,"numAffected":13,"numAtRisk":26},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":13},{"groupId":"EG007","numEvents":30,"numAffected":15,"numAtRisk":53},{"groupId":"EG008","numEvents":52,"numAffected":25,"numAtRisk":47},{"groupId":"EG009","numEvents":6,"numAffected":5,"numAtRisk":28},{"groupId":"EG010","numEvents":10,"numAffected":9,"numAtRisk":14},{"groupId":"EG011","numEvents":16,"numAffected":8,"numAtRisk":17}]},{"term":"Toothache","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":3,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":4,"numAffected":3,"numAtRisk":9},{"groupId":"EG003","numEvents":5,"numAffected":2,"numAtRisk":9},{"groupId":"EG004","numEvents":7,"numAffected":6,"numAtRisk":7},{"groupId":"EG005","numEvents":27,"numAffected":13,"numAtRisk":26},{"groupId":"EG006","numEvents":3,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":21,"numAffected":15,"numAtRisk":53},{"groupId":"EG008","numEvents":14,"numAffected":11,"numAtRisk":47},{"groupId":"EG009","numEvents":11,"numAffected":9,"numAtRisk":28},{"groupId":"EG010","numEvents":11,"numAffected":8,"numAtRisk":14},{"groupId":"EG011","numEvents":13,"numAffected":8,"numAtRisk":17}]},{"term":"Asthenia","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":2},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":3,"numAffected":3,"numAtRisk":7},{"groupId":"EG005","numEvents":37,"numAffected":15,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":23,"numAffected":14,"numAtRisk":53},{"groupId":"EG008","numEvents":31,"numAffected":18,"numAtRisk":47},{"groupId":"EG009","numEvents":10,"numAffected":7,"numAtRisk":28},{"groupId":"EG010","numEvents":13,"numAffected":8,"numAtRisk":14},{"groupId":"EG011","numEvents":14,"numAffected":5,"numAtRisk":17}]},{"term":"Chest discomfort","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":3,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Chills","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":6,"numAffected":5,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":7,"numAffected":6,"numAtRisk":53},{"groupId":"EG008","numEvents":7,"numAffected":5,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Discomfort","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Face oedema","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":3,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":1},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":7,"numAffected":4,"numAtRisk":9},{"groupId":"EG003","numEvents":8,"numAffected":6,"numAtRisk":9},{"groupId":"EG004","numEvents":10,"numAffected":7,"numAtRisk":7},{"groupId":"EG005","numEvents":38,"numAffected":17,"numAtRisk":26},{"groupId":"EG006","numEvents":7,"numAffected":4,"numAtRisk":13},{"groupId":"EG007","numEvents":63,"numAffected":32,"numAtRisk":53},{"groupId":"EG008","numEvents":68,"numAffected":33,"numAtRisk":47},{"groupId":"EG009","numEvents":17,"numAffected":11,"numAtRisk":28},{"groupId":"EG010","numEvents":2,"numAffected":2,"numAtRisk":14},{"groupId":"EG011","numEvents":25,"numAffected":8,"numAtRisk":17}]},{"term":"Feeling cold","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Feeling jittery","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Gait disturbance","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Influenza like illness","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Malaise","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":5,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":10,"numAffected":10,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Medical device pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Mucosal inflammation","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":3,"numAffected":2,"numAtRisk":9},{"groupId":"EG003","numEvents":4,"numAffected":3,"numAtRisk":9},{"groupId":"EG004","numEvents":9,"numAffected":5,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":4,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":11,"numAffected":7,"numAtRisk":53},{"groupId":"EG008","numEvents":12,"numAffected":6,"numAtRisk":47},{"groupId":"EG009","numEvents":4,"numAffected":4,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":8,"numAffected":4,"numAtRisk":17}]},{"term":"Non-cardiac chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":5,"numAffected":5,"numAtRisk":53},{"groupId":"EG008","numEvents":7,"numAffected":5,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Oedema","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Oedema peripheral","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":4,"numAffected":3,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":6,"numAffected":5,"numAtRisk":26},{"groupId":"EG006","numEvents":4,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":14,"numAffected":11,"numAtRisk":53},{"groupId":"EG008","numEvents":30,"numAffected":14,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":4,"numAffected":3,"numAtRisk":17}]},{"term":"Pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":3,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Peripheral swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":4,"numAffected":3,"numAtRisk":9},{"groupId":"EG004","numEvents":6,"numAffected":4,"numAtRisk":7},{"groupId":"EG005","numEvents":9,"numAffected":5,"numAtRisk":26},{"groupId":"EG006","numEvents":4,"numAffected":4,"numAtRisk":13},{"groupId":"EG007","numEvents":18,"numAffected":13,"numAtRisk":53},{"groupId":"EG008","numEvents":14,"numAffected":8,"numAtRisk":47},{"groupId":"EG009","numEvents":3,"numAffected":3,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":3,"numAffected":2,"numAtRisk":17}]},{"term":"Thirst decreased","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Xerosis","organSystem":"General disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hyperbilirubinaemia","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":11,"numAffected":6,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Drug hypersensitivity","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Hypersensitivity","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Angular cheilitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Candida infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Conjunctivitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Cystitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Ear infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Escherichia urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Eyelid infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Folliculitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":3,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Fungal infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Fungal skin infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":3,"numAffected":1,"numAtRisk":17}]},{"term":"Incision site infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Klebsiella infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Lower respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Oral fungal infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Paronychia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":4,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Perineal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Pharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Rhinitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":2,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Skin infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Tooth abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Tooth infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":1,"numAtRisk":17}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":8,"numAffected":7,"numAtRisk":47},{"groupId":"EG009","numEvents":4,"numAffected":3,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":10,"numAffected":7,"numAtRisk":53},{"groupId":"EG008","numEvents":16,"numAffected":9,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":3,"numAffected":3,"numAtRisk":17}]},{"term":"Excoriation","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":7,"numAffected":4,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Incision site pain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Post procedural haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Post procedural swelling","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Procedural pain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":3,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Scar","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Traumatic fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Wound complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Wound dehiscence","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Alanine aminotransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":22,"numAffected":16,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":1,"numAtRisk":17}]},{"term":"Ammonia increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":4,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Amylase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Aspartate aminotransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":46,"numAffected":23,"numAtRisk":53},{"groupId":"EG008","numEvents":9,"numAffected":5,"numAtRisk":47},{"groupId":"EG009","numEvents":3,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":2,"numAffected":2,"numAtRisk":14},{"groupId":"EG011","numEvents":3,"numAffected":2,"numAtRisk":17}]},{"term":"Blood alkaline phosphatase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":23,"numAffected":12,"numAtRisk":53},{"groupId":"EG008","numEvents":7,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Blood bilirubin increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":12,"numAffected":6,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":2,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Blood cholesterol increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Blood creatine phosphokinase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":4,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":6,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":6,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":11,"numAffected":3,"numAtRisk":14},{"groupId":"EG011","numEvents":4,"numAffected":3,"numAtRisk":17}]},{"term":"Blood creatinine increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":22,"numAffected":9,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":35,"numAffected":12,"numAtRisk":53},{"groupId":"EG008","numEvents":22,"numAffected":12,"numAtRisk":47},{"groupId":"EG009","numEvents":7,"numAffected":5,"numAtRisk":28},{"groupId":"EG010","numEvents":12,"numAffected":6,"numAtRisk":14},{"groupId":"EG011","numEvents":7,"numAffected":3,"numAtRisk":17}]},{"term":"Blood lactate dehydrogenase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Blood thyroid stimulating hormone decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Blood thyroid stimulating hormone increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Blood urea increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":5,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":6,"numAffected":4,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Breath sounds abnormal","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Ejection fraction decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Escherichia test positive","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Gamma-glutamyltransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":3,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Glycosylated haemoglobin increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":9},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Lipase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":5,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":6,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":3,"numAffected":1,"numAtRisk":17}]},{"term":"Lymphocyte count decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Neutrophil count decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Platelet count decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":9,"numAffected":4,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Pulse pressure increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Tandem gait test abnormal","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Thyroxine free increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Weight decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":9},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":12,"numAffected":9,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":24,"numAffected":17,"numAtRisk":53},{"groupId":"EG008","numEvents":10,"numAffected":7,"numAtRisk":47},{"groupId":"EG009","numEvents":5,"numAffected":5,"numAtRisk":28},{"groupId":"EG010","numEvents":3,"numAffected":3,"numAtRisk":14},{"groupId":"EG011","numEvents":4,"numAffected":4,"numAtRisk":17}]},{"term":"Weight increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"White blood cell count decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Cell death","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":3,"numAffected":1,"numAtRisk":17}]},{"term":"Decreased appetite","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":6,"numAffected":4,"numAtRisk":9},{"groupId":"EG003","numEvents":6,"numAffected":4,"numAtRisk":9},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":7},{"groupId":"EG005","numEvents":34,"numAffected":19,"numAtRisk":26},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":13},{"groupId":"EG007","numEvents":52,"numAffected":34,"numAtRisk":53},{"groupId":"EG008","numEvents":33,"numAffected":21,"numAtRisk":47},{"groupId":"EG009","numEvents":22,"numAffected":15,"numAtRisk":28},{"groupId":"EG010","numEvents":11,"numAffected":6,"numAtRisk":14},{"groupId":"EG011","numEvents":22,"numAffected":11,"numAtRisk":17}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":11,"numAffected":10,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":18,"numAffected":13,"numAtRisk":53},{"groupId":"EG008","numEvents":30,"numAffected":14,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":8,"numAffected":4,"numAtRisk":17}]},{"term":"Fluid retention","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":3,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hypercholesterolaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hyperglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":8,"numAffected":4,"numAtRisk":9},{"groupId":"EG003","numEvents":11,"numAffected":4,"numAtRisk":9},{"groupId":"EG004","numEvents":5,"numAffected":3,"numAtRisk":7},{"groupId":"EG005","numEvents":37,"numAffected":14,"numAtRisk":26},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":13},{"groupId":"EG007","numEvents":75,"numAffected":32,"numAtRisk":53},{"groupId":"EG008","numEvents":38,"numAffected":15,"numAtRisk":47},{"groupId":"EG009","numEvents":22,"numAffected":10,"numAtRisk":28},{"groupId":"EG010","numEvents":16,"numAffected":8,"numAtRisk":14},{"groupId":"EG011","numEvents":20,"numAffected":7,"numAtRisk":17}]},{"term":"Hyperkalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":4,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":10,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Hyperlipasaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":1,"numAtRisk":17}]},{"term":"Hyperphagia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hypertriglyceridaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hypoalbuminaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":5,"numAffected":4,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":5,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Hypocalcaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":4,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":6,"numAffected":5,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":4,"numAffected":3,"numAtRisk":14},{"groupId":"EG011","numEvents":3,"numAffected":3,"numAtRisk":17}]},{"term":"Hypoglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hypokalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":10,"numAffected":6,"numAtRisk":26},{"groupId":"EG006","numEvents":3,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":12,"numAffected":8,"numAtRisk":53},{"groupId":"EG008","numEvents":18,"numAffected":11,"numAtRisk":47},{"groupId":"EG009","numEvents":16,"numAffected":10,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":3,"numAffected":3,"numAtRisk":17}]},{"term":"Hypomagnesaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":4,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":7,"numAffected":5,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":5,"numAffected":3,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":6,"numAffected":5,"numAtRisk":17}]},{"term":"Hyponatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":16,"numAffected":7,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":3,"numAffected":2,"numAtRisk":17}]},{"term":"Hypophosphataemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":12,"numAffected":7,"numAtRisk":26},{"groupId":"EG006","numEvents":3,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":28,"numAffected":11,"numAtRisk":53},{"groupId":"EG008","numEvents":3,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":9,"numAffected":5,"numAtRisk":28},{"groupId":"EG010","numEvents":4,"numAffected":2,"numAtRisk":14},{"groupId":"EG011","numEvents":5,"numAffected":3,"numAtRisk":17}]},{"term":"Malnutrition","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Metabolic acidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Metabolic alkalosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":9},{"groupId":"EG004","numEvents":4,"numAffected":2,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":5,"numAffected":4,"numAtRisk":53},{"groupId":"EG008","numEvents":11,"numAffected":6,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":2,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":3,"numAffected":1,"numAtRisk":17}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":3,"numAffected":2,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":6,"numAffected":5,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":4,"numAffected":4,"numAtRisk":53},{"groupId":"EG008","numEvents":12,"numAffected":10,"numAtRisk":47},{"groupId":"EG009","numEvents":4,"numAffected":4,"numAtRisk":28},{"groupId":"EG010","numEvents":4,"numAffected":4,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Bone pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":2,"numAffected":2,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Flank pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Joint stiffness","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Joint swelling","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Muscle atrophy","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Muscle spasms","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":7,"numAffected":5,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":2,"numAffected":2,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Muscle twitching","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Muscular weakness","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":3,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Musculoskeletal chest pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":4,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Musculoskeletal pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":4,"numAffected":4,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":3,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":3,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Neck pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":6,"numAffected":5,"numAtRisk":47},{"groupId":"EG009","numEvents":4,"numAffected":3,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":4,"numAffected":4,"numAtRisk":17}]},{"term":"Cancer pain","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Tumour pain","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Ageusia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Aphasia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":3,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Ataxia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Cerebral atrophy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Cognitive disorder","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Convulsion","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Coordination abnormal","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":3,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":8,"numAffected":6,"numAtRisk":26},{"groupId":"EG006","numEvents":4,"numAffected":3,"numAtRisk":13},{"groupId":"EG007","numEvents":7,"numAffected":7,"numAtRisk":53},{"groupId":"EG008","numEvents":17,"numAffected":13,"numAtRisk":47},{"groupId":"EG009","numEvents":3,"numAffected":3,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":3,"numAffected":2,"numAtRisk":17}]},{"term":"Dysarthria","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Dysgeusia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":5,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":14,"numAffected":11,"numAtRisk":53},{"groupId":"EG008","numEvents":13,"numAffected":8,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Dystonia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Facial paralysis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Facial paresis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Head discomfort","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":6,"numAffected":5,"numAtRisk":26},{"groupId":"EG006","numEvents":10,"numAffected":5,"numAtRisk":13},{"groupId":"EG007","numEvents":11,"numAffected":11,"numAtRisk":53},{"groupId":"EG008","numEvents":8,"numAffected":8,"numAtRisk":47},{"groupId":"EG009","numEvents":7,"numAffected":6,"numAtRisk":28},{"groupId":"EG010","numEvents":3,"numAffected":3,"numAtRisk":14},{"groupId":"EG011","numEvents":5,"numAffected":5,"numAtRisk":17}]},{"term":"Hemiparesis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":6,"numAffected":5,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hydrocephalus","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hypoaesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Incoherent","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Lethargy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Loss of consciousness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Memory impairment","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Myoclonus","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Neuropathy peripheral","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":5,"numAffected":4,"numAtRisk":47},{"groupId":"EG009","numEvents":3,"numAffected":3,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Paraesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":2,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":4,"numAffected":4,"numAtRisk":53},{"groupId":"EG008","numEvents":3,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Peripheral sensory neuropathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Presyncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Quadrantanopia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Restless legs syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Sensory loss","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Somnolence","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":4,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":4,"numAffected":3,"numAtRisk":17}]},{"term":"Speech disorder","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":4,"numAffected":4,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Tremor","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":3,"numAffected":2,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":4,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":1,"numAtRisk":17}]},{"term":"Upper motor neurone lesion","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Visual field defect","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":4,"numAffected":4,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"White matter lesion","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Affect lability","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Affective disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Aggression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Agitation","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Anhedonia","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Anxiety","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":3,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":4,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":3,"numAffected":3,"numAtRisk":28},{"groupId":"EG010","numEvents":2,"numAffected":2,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Confusional state","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Depressed mood","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":4,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":3,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":3,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":3,"numAffected":3,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Disorientation","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":3,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hallucination","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Insomnia","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":7,"numAffected":7,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Mania","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Mental status changes","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Nervousness","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Persistent depressive disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Psychotic disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Substance-induced psychotic disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Acute kidney injury","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Dysuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":6,"numAffected":5,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Glycosuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hypertonic bladder","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Micturition urgency","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Nephropathy","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Nocturia","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":4,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Oliguria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Pollakiuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":3,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":5,"numAffected":4,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Proteinuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":15,"numAffected":7,"numAtRisk":53},{"groupId":"EG008","numEvents":7,"numAffected":5,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":2,"numAffected":2,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]},{"term":"Renal failure","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":5,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":7,"numAffected":2,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Renal impairment","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Urinary incontinence","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":9},{"groupId":"EG003","numEvents":2,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":7},{"groupId":"EG005","numEvents":7,"numAffected":5,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":11,"numAffected":8,"numAtRisk":53},{"groupId":"EG008","numEvents":12,"numAffected":9,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":3,"numAffected":3,"numAtRisk":17}]},{"term":"Dysphonia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":4,"numAffected":3,"numAtRisk":9},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":9},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":7},{"groupId":"EG005","numEvents":29,"numAffected":15,"numAtRisk":26},{"groupId":"EG006","numEvents":3,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":13,"numAffected":10,"numAtRisk":53},{"groupId":"EG008","numEvents":15,"numAffected":10,"numAtRisk":47},{"groupId":"EG009","numEvents":3,"numAffected":3,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":9,"numAffected":7,"numAtRisk":17}]},{"term":"Dyspnoea exertional","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":4,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":4,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":5,"numAffected":5,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Haemoptysis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hiccups","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hypoxia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Laryngeal haemorrhage","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Nasal congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Nasal inflammation","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Oropharyngeal pain","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Paranasal sinus hypersecretion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Pleural effusion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":5,"numAffected":5,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Pneumonia aspiration","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Pneumonitis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":4,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Productive cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":3,"numAffected":2,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":4,"numAffected":4,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":2,"numAffected":2,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Pulmonary congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Sputum discoloured","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Throat irritation","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Upper-airway cough syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Wheezing","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":3,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Decubitus ulcer","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Dermatitis acneiform","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":7,"numAffected":4,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Dry skin","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":9,"numAffected":7,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":13,"numAffected":8,"numAtRisk":53},{"groupId":"EG008","numEvents":8,"numAffected":8,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":2,"numAffected":2,"numAtRisk":14},{"groupId":"EG011","numEvents":4,"numAffected":4,"numAtRisk":17}]},{"term":"Eczema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Erythema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":5,"numAffected":5,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Hyperkeratosis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Nail disorder","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":3,"numAffected":3,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":1,"numAtRisk":17}]},{"term":"Night sweats","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":3,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Palmar-plantar erythrodysaesthesia syndrome","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":11,"numAffected":5,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Pruritus","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":21,"numAffected":9,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":41,"numAffected":18,"numAtRisk":53},{"groupId":"EG008","numEvents":47,"numAffected":21,"numAtRisk":47},{"groupId":"EG009","numEvents":5,"numAffected":5,"numAtRisk":28},{"groupId":"EG010","numEvents":2,"numAffected":2,"numAtRisk":14},{"groupId":"EG011","numEvents":8,"numAffected":6,"numAtRisk":17}]},{"term":"Psoriasis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Purpura","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":2},{"groupId":"EG002","numEvents":2,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":4,"numAffected":2,"numAtRisk":9},{"groupId":"EG004","numEvents":4,"numAffected":3,"numAtRisk":7},{"groupId":"EG005","numEvents":13,"numAffected":8,"numAtRisk":26},{"groupId":"EG006","numEvents":5,"numAffected":4,"numAtRisk":13},{"groupId":"EG007","numEvents":18,"numAffected":12,"numAtRisk":53},{"groupId":"EG008","numEvents":39,"numAffected":18,"numAtRisk":47},{"groupId":"EG009","numEvents":6,"numAffected":5,"numAtRisk":28},{"groupId":"EG010","numEvents":6,"numAffected":3,"numAtRisk":14},{"groupId":"EG011","numEvents":19,"numAffected":4,"numAtRisk":17}]},{"term":"Rash erythematous","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":6,"numAffected":4,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Rash generalised","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Rash macular","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":7,"numAffected":4,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":26,"numAffected":7,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Rash maculo-papular","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":2,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":8,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":22,"numAffected":7,"numAtRisk":53},{"groupId":"EG008","numEvents":22,"numAffected":12,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Rash papular","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":5,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Rash pruritic","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":3,"numAffected":2,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":7,"numAffected":2,"numAtRisk":13},{"groupId":"EG007","numEvents":7,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Skin exfoliation","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Skin lesion","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":4,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":1,"numAffected":1,"numAtRisk":17}]},{"term":"Skin plaque","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Urticaria","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Deep vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Flushing","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":8,"numAffected":6,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Haematoma","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":15,"numAffected":3,"numAtRisk":53},{"groupId":"EG008","numEvents":0,"numAffected":0,"numAtRisk":47},{"groupId":"EG009","numEvents":0,"numAffected":0,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":0,"numAffected":0,"numAtRisk":17}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 19.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":1},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":2},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":7},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG007","numEvents":6,"numAffected":5,"numAtRisk":53},{"groupId":"EG008","numEvents":4,"numAffected":4,"numAtRisk":47},{"groupId":"EG009","numEvents":2,"numAffected":2,"numAtRisk":28},{"groupId":"EG010","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG011","numEvents":2,"numAffected":2,"numAtRisk":17}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication."},"pointOfContact":{"title":"Bristol-Myers Squibb Study Director","organization":"Bristol-Myers Squibb","email":"Clinical.Trails@bms.com","phone":"Please email"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2025-12-17"},"conditionBrowseModule":{"meshes":[{"id":"D009101","term":"Multiple Myeloma"},{"id":"D016403","term":"Lymphoma, Large B-Cell, Diffuse"},{"id":"D005909","term":"Glioblastoma"},{"id":"D006528","term":"Carcinoma, Hepatocellular"},{"id":"D002289","term":"Carcinoma, Non-Small-Cell Lung"}],"ancestors":[{"id":"D054219","term":"Neoplasms, Plasma Cell"},{"id":"D009370","term":"Neoplasms by Histologic Type"},{"id":"D009369","term":"Neoplasms"},{"id":"D020141","term":"Hemostatic Disorders"},{"id":"D014652","term":"Vascular Diseases"},{"id":"D002318","term":"Cardiovascular Diseases"},{"id":"D010265","term":"Paraproteinemias"},{"id":"D001796","term":"Blood Protein Disorders"},{"id":"D006402","term":"Hematologic Diseases"},{"id":"D006425","term":"Hemic and Lymphatic Diseases"},{"id":"D006474","term":"Hemorrhagic Disorders"},{"id":"D008232","term":"Lymphoproliferative Disorders"},{"id":"D007160","term":"Immunoproliferative Disorders"},{"id":"D007154","term":"Immune System Diseases"},{"id":"D016393","term":"Lymphoma, B-Cell"},{"id":"D008228","term":"Lymphoma, Non-Hodgkin"},{"id":"D008223","term":"Lymphoma"},{"id":"D008206","term":"Lymphatic Diseases"},{"id":"D001254","term":"Astrocytoma"},{"id":"D005910","term":"Glioma"},{"id":"D018302","term":"Neoplasms, Neuroepithelial"},{"id":"D017599","term":"Neuroectodermal Tumors"},{"id":"D009373","term":"Neoplasms, Germ Cell and Embryonal"},{"id":"D009375","term":"Neoplasms, Glandular and Epithelial"},{"id":"D009380","term":"Neoplasms, Nerve Tissue"},{"id":"D000230","term":"Adenocarcinoma"},{"id":"D002277","term":"Carcinoma"},{"id":"D008113","term":"Liver Neoplasms"},{"id":"D004067","term":"Digestive System Neoplasms"},{"id":"D009371","term":"Neoplasms by Site"},{"id":"D004066","term":"Digestive System Diseases"},{"id":"D008107","term":"Liver Diseases"},{"id":"D002283","term":"Carcinoma, Bronchogenic"},{"id":"D001984","term":"Bronchial Neoplasms"},{"id":"D008175","term":"Lung Neoplasms"},{"id":"D012142","term":"Respiratory Tract Neoplasms"},{"id":"D013899","term":"Thoracic Neoplasms"},{"id":"D008171","term":"Lung Diseases"},{"id":"D012140","term":"Respiratory Tract Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"C000601736","term":"CC-223"}]}},"hasResults":true}